CA2257989A1 - Catheter apparatus and method for creating a vascular bypass in vivo - Google Patents

Catheter apparatus and method for creating a vascular bypass in vivo Download PDF

Info

Publication number
CA2257989A1
CA2257989A1 CA002257989A CA2257989A CA2257989A1 CA 2257989 A1 CA2257989 A1 CA 2257989A1 CA 002257989 A CA002257989 A CA 002257989A CA 2257989 A CA2257989 A CA 2257989A CA 2257989 A1 CA2257989 A1 CA 2257989A1
Authority
CA
Canada
Prior art keywords
blood vessel
cuff
catheter
obturator
vivo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002257989A
Other languages
French (fr)
Inventor
Ducksoo Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beth Israel Deaconess Medical Center Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2257989A1 publication Critical patent/CA2257989A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/064Blood vessels with special features to facilitate anastomotic coupling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/320016Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3417Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00491Surgical glue applicators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/3205Excision instruments
    • A61B17/3207Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • A61B2017/00247Making holes in the wall of the heart, e.g. laser Myocardial revascularization
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00292Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00778Operations on blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • A61B2017/1107Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis for blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • A61B2017/1135End-to-side connections, e.g. T- or Y-connections
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00351Heart
    • A61B2018/00392Transmyocardial revascularisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0077Special surfaces of prostheses, e.g. for improving ingrowth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/30092Properties of materials and coating materials using shape memory or superelastic materials, e.g. nitinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/821Ostial stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • A61F2210/0019Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • A61F2210/0023Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02Holding devices, e.g. on the body
    • A61M2025/0213Holding devices, e.g. on the body where the catheter is attached by means specifically adapted to a part of the human body
    • A61M2025/0233Holding devices, e.g. on the body where the catheter is attached by means specifically adapted to a part of the human body specifically adapted for attaching to a body wall by means which are on both sides of the wall, e.g. for attaching to an abdominal wall
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/02General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0266Shape memory materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0021Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0023Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
    • A61M25/0026Multi-lumen catheters with stationary elements
    • A61M25/0032Multi-lumen catheters with stationary elements characterized by at least one unconventionally shaped lumen, e.g. polygons, ellipsoids, wedges or shapes comprising concave and convex parts

Abstract

The present invention provides a catheter apparatus (2), an introducer system (120), and a methodology for creating a vascular bypass on-demand between an unobstructed blood vessel, such as the aorta and an obstructed blood vessel (502) such as an obstructed coronary artery in vivo using a previously excised vascular segment as a shunt. The invention allows the placement and creation of single or multiple vascular grafts (300) without use of a heart/lung machine and without need for stopping the heart of the patient during the coronary artery bypass surgery.

Description

CATHETER APPARATUS AND METHOD FOR CREATING A VASCULAR
BYPASS IN-VIVO

~IELD OF THE INVENTION
The present invention is concer"ed generally with minimally invasive a, le, ial bypass surgery; and is di. e- ted to a catl ,ete~ i~ation ",etl ,odology for cr~dting a v~sa ll~r bypass betwecn an unoL sl, ucted artery or vein and an obstructed artery or vein in-vivo.
BACKGROUND OF THE INVENTION
Coronary artery disease is the single leading cause of human mortality and is annually (espo"sible for over 900 000 deaths in the United States alone. Additionally over 3 million Alllerica"s suffer chest pain (angina pectoris) becPuse of it. Typically the corona, y artery becornes narrowed over time by the build up of fat cholesle~ol and blood clots. This narrowing of the artery is called ~, ll ,erosclcrosis; and this condition slows the blood flow to the heart muscle (myocardium) and leads to angina pectoris due to a lack of nutrients and ~le~ te oxygen supply. So",elimes it can also coll,~ tely stop the blood flow to the heart causing per",a(,ent damage to the myocar~ium the so-called "heart attack."
The conventional lredl",ent procedures for corunary artery disease vary with the severity of the cûnJition. If the coro"a~y artery ~lise~se is rrild it is first l(ealed with diet and e~arc-se. If this first line of l(edt",enl is not effective then the condilion is lrea~ed with "~edications. However even with ",ecl;cAlions if chest pain pe, aisls (which is usually seconda(y to dcvelopment of serious coronary artery ~;s0~sc) the condilion is often lrealed with invasive proceclures to improve blood flow to the heart. Currently there are several types of invasive ~crocedures: (1) Call,eteri~ation techniques by which cardiologists use balloon cathe~,a dll,erecto",y devices or stents to reoper, up the blockage of co,unary arteries; or (2) Surgical bypass techniques by which su, yeol ,s surgically place a graft obtained from a sectionof artery or vein removed from other parts of the body to bypass the blockage.
Conventionally before the invasive proc~dures are begun corol1a, y artery angiog,aphy is usually pe,rO""e(J to evaluate the extent and severity of SUBSTITUTE SltEcT (RULE 26) the coronary artery blockages. Cardiologists or radiologists thread a thin catheter through an artery in the leg or arm to engage the coronary arteries.
X-ray dye (co"l(a~l medium) is then injected into the coro,la,y artery through a portal in the catheter, which makes the coronary arteries visible under X-ray, so that the position and size of the blockages in the coronary arteries canbe identified. Each year in U.S.A., more than one million individuals with angina pectoris or heart attack undergo coronary angiographies for evaluation of such coron~ y artery blockages. Once the blocked arteries are identified, the physician and surgeons then decide upon the best method to 10 treat them.
One of the medically accepted ways to deal with coronary arterial biockage is percutaneous transluminal corona~ y angioplasty (PTCA). In this procedure, cardiologists thread a balloon calheter into the blocked coronary artery and stretch it by ir,rlatir,g the balloon against the arterial plaques ~5 causing vascular blockage. The PTCA procedure immediately improves blood flow in the coronary arteries, relieves angina pectoris, and prevents heart attacks. Approximately 400,000 patients undergo PTCA each year in the U.S. However, when the arterial blockages are severe or widespread, the angioplasty procedure may fail or cannot be pel~""ed. In these instances, 20 coronary artery bypass graft (CABG) surgery is then typically pe,ror",ed. In such bypass surgery, surgeons harvest healthy blood vessels from another part of the body and use them as vascular grafts to bypass the blocked corol~ary arteries. Each v~scl~ graft is attached with one of its ends joined to the aorta and the other end joined to the coronary artery. Approxi",dlely 25 500,000 CABG operations are currently ~e~ rc~ led in the U.S. each year to relieve s~ ,p(o,ns and improve survival from heart attack.
It is useful here to un~ersta~ Id in depth what a coronary arterial bypass entails and dema"ds both for the patient and for the cardiac surgeon. In a standard coronary bypass operation, the surgeon must first make a foot-long 30 incision in the chest and split the breast bone of the patient. The operationrequires the use of a heart-lung machine that keeps the blood circulating while the heart is being stopped and the surgeon places and attaches the bypass grafts. To stop the heart, the coronary arteries also have to be perFused with a cold potassium solution (cardioplegia). In addition, the body 3~ ten~peralure of the patient is lowered by cooling the blood as it circulates SUBSTITUTE S~EET (RllLE 26) CA 022~7989 1998-12-09 W O 97/47261 PCTrUS97/09503-through the heart-lung ")achi"e in order to preserve the heart and other vital organs.
As the heart is slopped and a heart-lung machine pumps oxygenaled blood through the patient's body the surgeon makes a tiny opening into the ~ 5 front wall of the target c~ro,)a, y artery with a very fine knife (a, lerioto",y);
takes a previously ~)t.ci~ed sapl~enous vein (a vein from a leg) or an internal I l Idll ,ma, y artery (an artery from the chest); and sews the previously e~oised blood vessel to the coro"a~y artery. The most c~l"",Gn blood vessel harvested for use as a graft is the yl eater (long) sa,. henous vein which is a t 0 long slrai,yl ,l vein running from just inside the ankle bone to the groin. The greater sapl)enous vein provides a bypass conduit of the most desired size shape and length for use with corona, y arteries. The other blood vessel frequently used as a bypass graft is the left or right internal rna~llllldl y artery which comes off the subclavian artery and runs alongside the undersurface of the brea:,lbone (sternum). Typically the internal mammary artery ren,di"s dtla~ ,ed to the subcl-vian artery proxi"~ally (its upper part) but is freed up distally (its lower part); and it is then a"as~on,osed to the corona,y artery.
However the saphenous vein graft should be sewn not only to cor~,l ,a, y artery but also to the aorta since the excised vein is detached at both ends.
Then to create the anasto,nosis at the aorta the ascending lhoracic aorta is first partially clamped using a curved v~scul~r clamp to occl- ~de the proper seg" ,ent of the ascending aorta; and a hole is then created through the front wall of the aorta to a n~ I ,or the vein graft with sutures. The graft byp~-sses the blockage in the co, ona, y artery and restores adequate blood flow to the heart. After completion of the y, ~ling the patient is taken off of the heart-lung ~l~achine and the patient s heart starts bedlirly again. Most of the patients can leave the l~ospilal in about 6 days after the CABG procedure.
It will be noted that corona~y artery bypass surgery is considered a more dt:ril litive method for lrealing ~ror,a, y arterial ~ise~se bec~use all kinds of obstructions cannot be l, ~ated by angioplasty; and be~ ~se a recurrence of blockages in the ~rona~ y al l~ries even after angioplasty is not unusual. Also coronary artery bypass surgery usually provides for a longer ~calel)cy of the grafts and the bypassed co,onary arteries in col"p~,ison with the results of PTCA procedure. I loN~vcr coronaly artery bypass surgery is a far more complicated plocedure having need of a heart-lung ",acl,ine and a stoppage of the heart. Also it is clearly the more invasive ~c rocedure and is SUBSTITUTE SHEET (RULE 26) CA 022~7989 1998-12-09 more expensive to ~ue~ rO" " than PTCA. Tl ,ererore cardiac surgeons have recently developed an alle, I ,alive to the standard bypass surgery namely minimally invasive bypass oper~lion (MIBO) in order to reduce the risks and the cost associated with CABG surgery. Also the MIBO is performed without 5 use of a heart-lung macl~ine or the stopping of the heart.
There are several ways that n,.n.lnally invasive coronary bypass surgeries are being done today. Some versions are modeled after the video-assisled fiber-optic te~;l " ~iques dc~eloped previously for gallbladder and other general surgeries. Other teol")i~ues have modified dec~les-old 10 methods to sew arterial grafts onto beating hearts without using heart-lung ",achi"es. In the new and most popular version of the minimally invasive coronary bypass operation surgeons use a thoracoscope a fiber-optic device that is similar to a laparoscope. Initially a three-inch incision is madeto the left of the breast bone through which the surgeo"s operate. Three 15 addilional one-inch incisions then are made to insert a video camera knife surgical stapler and other instruments. In the first stage of the operation surgeons prepare the internal ma"""~,y artery which courses vertically behind the rib cage while watching on a video monitor. The internal mammary artery is freed up distally and is then sewn to the left anterior 20 desce"ding coronary artery. The inler"al mammary artery thus supplies blood to the coro"ary artery in place of blocked circulation of the heart. The wall of the chest ror",erly served by the ~a",ma,y artery picks up blood from elsewhere via collateral blood circulations.
As a bypass graft the left internal "~a"~,na~y artery (LIMA) offers a 25 number of advantages to the coro, lary artery surgery including higher patency rate; and anat~",ically hislologically and geometrically provides a more cor ,pa~dble graft than the saphenous vein graft. LIMA is particularly useful as a graft to the colc,l,a.y arteries such as the left anterior desce".ling diagonal branches and ramus intermedius arteries (which are located on the 3~ surface of the heart relatively close to the left internal r"al "" ,a~ artery).
However there are several disadva,llages associaled with a CABG operali with a left internal l,,d,.,,,,aly artery graft which are as follows: (1) technically this artery is more tedious to take down; (2) sometimes the left internal man""ary artery is inadequate in size and length; (3) the operation is suitable 35 only for the five percent of cal1did 3les for corona, y artery bypass becauseonly a single left internal l"a"""ary artery is available as a graft; (4) SUBSTITUTE SHEET (RU~.~ 26) andto,nically the operation is limited mainly to the left ante,ior descending coronary arter because of its lo~tiol1 ad length; and (5) the maiority of palie, lls need more than single vessel bypass surgery.
In co""~a, ison coronary a, leries as small as 1 mm in diameter can be 5 rev~sc~ ed by vein gr~li"g and the saphenous vein is longer larger and more ~ccessi~-le than the left inlen~al n~amma~y artery. Equally in,p~,lanl although the y,ealer or lesser saphenous veins of the leg are ~refe"e~ the ce~Jhalic or basilic veins in th ann are available as allel "ali~es when the legveins in the patient are unavailable or are unsuitable. For these reasol ,s the 10 vein graft has today become the standard conduit for myocardial revascul~ri~ation.
There re",dins however a long-sla"ding and continuing need for a bypass te~;l ,n;q~le which would allow sulgeons to pe, ror", multiple bypass procedures using vein grafts as vascular shunts in a mil,in,ally invasive way;
15 and in particular the need remains for a simplemlletllod to place more than one vein graft proxin,ally to the aorta and distally to the corona,y artery without using a heart-lung ",acl~ine and without slopl,i"~ the heart. If such a technique were to be crealed it would be recogni~ed as a ma30r advance in bypass surgery and be of s~ tial benefit and advanLage for the patient 20 suffering from corona, y artery di .ea .c.

SUMMARY OF THE INVENTION
The present invention has multiple aspect~. A first aspect is a ca~l ,eter a~.pa,at.ls for creating bypass on-de",and between an u, lobsl, ucted artery 25 and an obstructed artery in-vivo using a previously excised v~sa~l~r segment as a conduit said vascular bypass catheter apparalus comp, ising:
a catl ,eter sl ~itahle for introduction into and e~lension through the body in-vivo said call,eler being cG",p,ised of (a) a hollow tube of fixed axial length having a discrete 30 p(w(illlal end a discrete distal end and at least one internal lumen of .redete,lllineddia"~eter and (b) a distal end tip ~d~rted for guidance of said cath~ler in-vivo to a cl ,osen site wherein an uno~ ucted artery is in anator"ic proximity to an obstruction Iying within another artery;

SUBSTITUTE SHEET (RULE 26) CA 022~7989 1998-12-09 W O 97147261 PCTrUS97/09503-an obturator for on-demand introduction and p~ss~ge through said catheter to a chosen site on the unobstructed artery in-vivo said obturator comprising (1 ) an expandable and conLra~;tible puncturing headpiece for 5 puncture of and entry into the lumen of an unol~sl, ucted artery said puncturing headpiece being ex~,dndable on-demand to a size g~a~er than the .lia",eter of said in~er"al lumen of said catl,eter and being conlr~ctible on-demand to a size less than the diameter of said internal lumen of said catheter (2) a pe, roraling end tip on said puncturing l-eadpiece to facilitate the pe, ruralion of an arterial wall at the chosen site in-vivo (3) an elG"gate-i shaft of fixed axial length integrated with said puncturing headpiece said elongated shaft being configured for the carrying and l, dnspo, ~ of the previously excised vascular segment within said 15 i"ter"al lumen of said ~tl ,eter to the chosen vascular site on the unobstructed artery in-vivo (4) means for expanding and contracting said puncturing headpiece of said obturator on-de",a".3; and a deron~able cuff for positioning over said elongated shaft ~dj~cent to 20 said puncturing headpiece of said obturator together with a previously excised vascular segment (i) wherein prior to the pe, roralion of the unobstructed artery in-vivo by said puncturing t ,e&d,~,icce of said obturator at least a portion of said de~r,nable cuff has been engayed and joined to one end of 25 the excised vascular segment then carried by said elongated shaft of said obturator (ii) and wherein after the pe, rO, aliol1 of the unobstructed artery in-vivo by said puncturing headpiece of said obturator at least part of said engaged cuff is extended into the lumen of the unobstructed artery is 30 partially deformed in-situ by an expansion of said puncturing head,~,ioce of said obturator and said e"gage-i cuff becomes attached via said partial deformation to the interior of the unobstructed artery (iii) and whereby said cuff engaged end of the previously excised v~sclll~r segment become secured to and placed in blood flow 35 communication with the unobstructed artery and serves as vascular conduit SUBSTITUTE S~IEET (RULE 26) means for bypassing an obstruction and r~slo, i"g arterial blood flow from the unobstructed artery to the obstructed artery.
~ A second aspect of the invention .lefi, 'es a ~tl ,eri~alion ,nethod for creating a v~sculnr bypass on-der~,and between an unobstructed artery and 5 an obstructed artery in-vivo using a previously excised v~sclJ~r segment as a conduit said vasu~l~r bypass c~theteri~ation ",eU,od co"".risi"~ the steps of:
providing a cdll ,eter suitable for introduction into and eklension through the body in-vivo said catl~eter being comprised of (a) a hollow tube of fixed axial length having a .liscrete 10 proxi",al end a discrele distal end and at least one internal lumen of pr~deter,ni.,eddiameter and (b) a distal end tip adapted for guidance of said catl ,eter in-vivo to a ci ,os~n V~SGIJl~ site wherein an uno~lructed artery is in analor"ic pro~in,ily to an obstruction Iying within anoll-er artery;
providing an obturator for on--Je,nand introduction and p~ss~e through said ~tl ,eter to a ~ I ,osen site on the u, lo~sl, ucted artery in-vivo said obturator COIllyl ising (1 ) an ex~.andable and contractible puncturing headpiece for puncture of and entry into the lumen of an ~"obsl, ucted artery said puncturing headpiece being ek~.andable on-.Jen~and to a size y,ealer than the dia,~,eter of said internal lumen of said catl,eter and also being co, Itl a-;tible on-de",ar,d to a size less than the di~,ne~er of said inle" ,al lumen of said catl ,eter (2) a pe, roratin~ end tip on said puncturing head~ieoe to facilitate the pe~ rordtio n of an arterial wall at the cl ,osen v~scl ll~r site in-vivo (3) an elongaled shaft of fixed axial length inte~,ated with said puncturing headpiece said elongaled shaft being configured for the carrying and tra,1spo, l of a previously excised v~scul~r sey"~ within said internal lumen of said catheter to the chosen site on the unobstructed artery in-vivo (4) means for ex~.and."~ and contracting said puncturing headpiece of said obturator on-de",ar,d;
placing a previously eAcised v~scul~r segment on the elor"3aled shaft ~- 5 Icenl to said puncturing headpiece of said obturator;
positioning a defo"nabl~ cuff over said elongated shaft and one end of the previously excised vascular segment Iying adjacent to saia puncturing SUBSTITUTE SHEET (RULE 26) CA 022~7989 1998-12-09 W O97/47261 PCTrUS97/09503-headpiece of said obturator such that at least a portion of said defon~,able cuff engages and is joined to the end of the excised vascular se~",~"l, pe, ror~ling the ~nol~sll ucted artery at the chose~ ~ site in-vivo using said puncturing headpiece of said obturator;
e~e"di"g at least part of said engaged cuff into the lumen of the unobstructed artery;
partially ~lefor"ling said exte~ ,ded cuff in-situ by an expansion of said puncturing headpiece of said obturator (i~ whereby said engaged cuff becGmes allacl ,ed via said partial derol",aLion to the interior of the unobstructed artery, (ii) and whereby said cuff engaged end of the previously excised vascular segment become secured to and placed in blood flow communication with the unobstructed artery; and joining the other end of the secured vascular segment to the obstructed artery at a chosen site distal to the obstruction, said joined segment serving as a v~sc~ r conduit means for bypassing the obstruction and restoring arterial blood flow from the unobstructed artery to the obstructed artery.

BRIEF DESCRIPTION OF THE FIGURES
The present invention may be more easily and completely understood when taken in conjunction with the acco",~anying drawing, in which:
Fig. 1 is an overhead view of a conventionally known first catheter;
Fig. 2 is an overl ,ead view of a conventionally known second catheter;
Figs. 3A and 3B are perspective and cross-sectional views of a single walt catheter tube of normal thickness, Figs. 4A and 4B are perspective and cross-sectional views of a single wall catheter tube of reduced thickness;
Figs. 5A and 5B are perspective and cross-sectional views of a multiple-wall catheter tube of normal thickness;
Figs. 6A and 6B are perspective and cross-sectional views of a multiple-wall catheter tube of reduced thickness;
Figs. 7A-7D are cross-sectional views of four different constructions of dual-lumen catheters;
Fig. 8 is an illustration of the distal end of a conventionally known guiding catheter;
SUBSTITUTE SHEET (RULE 26) CA 022~7989 1998-12-09 _ 9 _ Fig. 9 is a pel~pe~;ti~re view of a ,..,erer,~d first obturator;
Fig. 10 is a frontal view of the first obturator of Fig. 9;
Fig. 11 is a side view of the puncturing headpiece of the first obturator shown in Fig. 9;
Fig. 12 is a side view of the puncturing headpiece of Fig. 11 when in a contracted state;
Fig. 13 is a side view of the puncturing head~,iece of Fig. 11 when in an expanded state;
Fig. 14 is an ex~.osed view of a l"echar,ical assen~bly used for ex~d"ding and co"L, acting a puncturing headpiece on-demand in an obturator;
Fig. 15 is an exposed view of a hydraulic asse,nbly for e,~,~)anding and conlra.:ti"g a puncturing headpiece on-de",a"d in an obturator;
Fig. 16 is a per~,e~ e view of a second obturator;
1~ Fig. 17 is a frontal view of the second obturator of Fig. 16;
Fig. 1~ is a perspective view of a third obturator;
Fig. 19 is a frontal view of the third obturator of Fig. 18;
Fig. 20 is a side view of an alternative fourth puncturing headpiece of an obturator;
Fig. 21 is a side view of an alternative fifth puncturing I ,ead,~,iece of an obturator;
Fig. 22 is a side view of an allernali~/e sixth puncturing he~r~riace of an obturator;
Fig. 23 is an overhead view of a prefe"ed first defo""able cuff in the original Ul ~defo""ed state;
Fig. 24 is an overhead view of the pr~rer,ed first deror",able cuff of Fig. 23 after defor",dlion;
Fig. 25 is an overhead view of a preferr~d second defoll,lable cuff in the original ~",defor"~ed state;
Fig. 26 is an overhead view of an allerndli~e third deformable cuff in the original undef~""ed state;
Fig. 27 is an overhead view of an alternative fourth d~for",d~le cuff in the original u"deror,ned state;
Fig. 28 is a perspective view of a previously excised v~sc~ segment 3~ position on the elongated shaft of the prerened first obturator of Fig. 9;

SUBSTITUTE SHEET (RULE 26) CA 022~7989 l998-l2-09 W O 97/47261 PCT~US97/09503-Fig. 29 is a perspective view of the prerer, ed first deformable cuff of Fig. 23 in com~ination with the previously excised vascular segment shown in Fig. 28;
Fig. 30 is a partially exposed view of the introducer system as a whole;
Figs. 31A-31 F are illusl(dlio"s of the modified Seldinger technique conventionally used for percutaneous catherteri~alion;
Fig. 32 is a partially exposed view of the introducer system in the c~re~ position at the exterior wall of an unobstructed b~ood vessel in-vivo;
Fig. 33 is a partially eh~osed view of the prepared obturator penetrating the vascular wall of the unobstructed blood vessel in-vivo;
Fig. 34 is a partially exposed view of the prepared obturator entering the internal lumen of the unobstructed blood vessel in-vivo;
Fig. 35 is a partially exposed view of the puncturing headpiece in a contracted state while disposed within the internal lumen of the u, lubsll uctedblood vessel in-vivo;
Fig. 36 is a partially exposed view of the defûrmable cufl and engaged over the puncturing headpiece within the internal lumen of the unobstructed blood vessel in-vivo;
Fig. 37 is a partially exposed view of the subsequently expanded puncturing headpiece and the deformed cuff disposed within the internal lumen of the unobstructed blood vessel in-vivo;
Fig. 38 is a partially exposed view of the puncturing headpiece in the seconda, y co"Iract~d state after deformation of the cuff within the i"ler"al lumen of the unobstructed blood vessel in-vivo;
Fig. 39 is a partially exposed view of the .leforr"ed cuff and vascular segment secured fluid-tight to and in blood flow communication with the internal lumen of the unobstructed blood vessel in-vivo;
Fig. 40 is a partially exposed view of the vascular bypass ~rafted and secured to the unobstructed blood vessel in-vivo; and Fig. 41 is a partially e,~,~)osed view of the other open end of the vascular segment anasIol "osed in the conventionally known manner to an obstructed blood vessel.

SUBSTITUTE SllEET (I~ULE 26) CA 022~7989 1998-12-09 W O 97/47261 PCT~US97/09503-DETAILED DESCRIPTION OF THE INVENTION

The p,ese"l invention is a cath~ter ~uparatLJs and ~LI ,eri,alion technique for creating a single v~sa ~l~ bypass or multiple v~sc~ ~nr byp~sses 5 on~lema~cl between an unobslnJcted blood vessel such as the aorta and an obstructed blood vessel such as an obstructed coro"ary artery in-vivo. The present invention utilizes a previously excis~d v~ca ~ segment as a conduit;
and employs an introducer system using the catl,~ter ap~,aral-Js and excised vascularl sey",e, h in combination to create single or multiple shunts which t0 overco,l,e the obstruction and deliver arterial blood from a primary blood vessel around the obstruction and into a secor)da"/ artery or vein in order to increase and/or maintain proper blood circulation in the living body. A
number of s~ slAntial advantages and major benefits are tl ,erefo,~ provided by the presenl invention some of which include the following:
1. The presenl invention provides the means for surgeons to ,.,e,ro(", multiple bypass grafts in a ~r~inimally invasive manner. The methodology permits the surgeon to utilize previously excised veins as bypass grafts and allows the surgeon to place each of the vein grafts from a primary unobstructed artery (such as the aorta) to a secondary obstructed 20 artery (such as the obstructed co,c,nd"~ artery) without using a heart-lung ",achine and without need for slopp;. ,y the heart during the surgery.
2. The present invention simplifies the complexity of conventional bypass surgery and makes the surgery less invasive. Moreover the technique provides the ability to create multiple bypass conduits using a 25 catl ,elerization proc~dure which not only sl ,o, le"s the conventional operation time for surgery but also makes the bypass surgery safer and more cost effective.
3. The present invention is suitsble for cre~ing a single bypass graft or multiple bypass grafts in any medical situation condition or 30 pathology in which there is a need for inc,eased blood flow to a speci~ic blood vessel or v~sc~ r area or body region. The cause or source of the Illedical problem may be an obstruction in a blood vessel; or a narrowing or thickening of a blood vessel wall; or a diminution or narrowing of a v~su ll~r section in aparticular blood vessel. Each of these ,nedical conditions has its particular 35 cause origin or source; and each of these pathologies though clirrarel ,t in origin causes a similar effect overall -- a loss of blood flow and blood SUBSTITUTE SHEET (RULE 26) CA 022C77989 l998-l2-09 pressure within the blood vessel. Accordingly, the present invention is deemed useful and desirable to overco~e any of these particular medical conditions and instances where there is a demGn~l~ ated need for increased blood pressure and blood volume flow within a particular blood vessel or blood flow region in the body.
4. The present appara(. s and methodology can be employed to create a v~ss~ bypass between any two blood vessels. In many irl:~lances, the v~scl ll~r bypass graft is made between a primary u~lobsl~ ucted artery and a secondary obstructed artery, a typical exal"ple being a v~sc~ r bypass 10 between the ascending aorta and an obstructed coronary artery. However, a v~sull~r bypass shunt may atso be c,ealed between any two veins (such as between the portal vein and the inferior vena cava); or between an artery and a vein (such as between the superior vena cava and a pul~llona,y artery).
Equally important, although the primary focus of the present invention is the 15 thoracic cavity and the recognized need for vascular bypass conduits among the blood vessels found therein, the present apparalus and methodology may be employed anywhere in the human body where there is a need for increased v~scularization or revascularization of the local region. The sole limitation, thererore, is a means of ~ccess for the catheter apparatus, the 20 introducer system, and the methodology to be performed by the skilled surgeon and invasive radiologist.
In order to provide a complete and comprehensive ur,der~la, nling of the present invention, the detailed description is given as a series of individual sections presented seriatim. These will include the following: the 25 cor"ponent parts of the ca(l~eter apparalus; the excised blood vessel segmentto be used as a v~-sc~ r conduit; the introducer system utilizing the catheter a7u7uaral7. s and excised vascular segment in combination; general techniques of catheter routing and surgical introduction; the methodology and individual manipulations for creating a vascular graft; and an illustrative summary of the 30 pre~e"ed surgical procedures using the catheter apparalus7 introducer system, and methodology. Each of these will be desoribe(l and cl ,aracteri~ed individually.

SUBSTITUTE- SH7tET (RULE 26) CA 022~7989 1998-12-09 W O 97/47261 PCT~US97/09503-1. The Component Parts of the Catheter Apparatus Three ess~nlial co",pon~rlt parts comprise the catl,eter apparatus needed to create a vAscl ll~r bypass in-vivo. These are: a flexible guiding catheter an obturator having a puncturing he~lriece which is expandable and conl~a~;tible on-de"~a,)d; and a defo,l"able cuff for engaging and securing a previously excised vasull~rl segment as a graft to an Ul lo~sl"~cted major blood vessel (such as the aorta). Each of these component parts will be descl ibed in detail individually.
A. The Flexible Guiding Call ,eter The in-vivo bypass catl,eteri~alion ",etl,od comprising the p,esent invention requires that a controlling or guiding flexible catheter be employed as an essential part of the appar~lus and manipulations. This controlling or guiding flexible catl ,eter has at least one tubular wall of fixed axial length; has at least one proxirnal end for entry; has at least one distal end for egress; and has at least one internal lumen of a volume sufficient to allow for on-de",dl Idcontrolled p~ss~ge ll ,erell)rough of a prepared obturator carrying a cuff and apreviously excise.l v~scl~ sey"l~nl.
Catheters particularly surgical catheters are conventlonally known and used; and a wide range and variety of guiding cdtl,ete~ are available which are exll ~n,ely diverse in shape design and specific features. All of the esser,lial requirements of a guiding flexible call,eter exist as conventional knowledge and inro",~alion in the relevant te.;hnical field; and all of the in~u""ation regardir,g caU~eter design and provided in summary fonn I ,ereir,~rler is publicly known widely disseminated and published in a variety of auU ,orildli~e texts. The reader is lhereror~ presumed to be both familiar with and have an in-depth knoY. Iedge and u "~erslancl;"g of the conve, ItiOI ,al diagnostic and ll ,erapeutic uses of catheters and calhe~ alion techniques.
Merely re~resenlali~/e of the diversity of publications publicly available are the following each of which is e~,ressly incorporated by r~rerence herein:
Dia~"oslic and TheraPeutic Cardiac Cdtl,e,li~alion second edition (Pepine Hill and Laml~el l editors) Williams & Wilkins 1994 and the re~ere"ces cited therein; A Practical Guide To Cardiac Pacing fourth edition (Moses et. al.
editors) Little Brown and Col~"~any 1995 and the rerer~"ces cited therein;

SUBSTITUTE SHEEt (RULE 26) CA 022~7989 1998-12-09 W O 97/47261 PCT~US97/09503-Abrams An~ioqraPhy, third edition (H. L. Abrams, editor), Little, Brown, and Company, 1983.
A number of specific types of co, Itl olling or guiding catheters are known today; but for purposes of practicing the present invention, a number of newly designed or specifically designed catheters of varying lengths and sizes suitable for bypass use are exp~led and intended to be developed and manufactured subsequently. Equally i"~po, lant, minor modifications of the presently existing ge"erdl categories of catheters are equally appropriate and are ex~Je~;ied to be found suitable for use when practicing the present invention. Accordingly, a summary review of the conventionally known catheter types as well as a summary description of general cdlheter design and the principles of catheter construction are presented herein.
Catheter Construction and Desiqn:
Presently known specific types of catheters include the following:
central venous call,eter~ which are relatively short (usually 20-60 cel ,li"~eters) in length and are designed for insertion into the internal jugular or subclavian vein; right heart call ,eters such as the Coumard catheter designed specifically for right heart cathete, i,alion; transseptal catheters developed specifically for crossing from right to left atrium through the interarterial septum at the fossa ovalis; angiographic catheters which are varied in shape and are frequently used today in the femorial and brachial approach for cardiac ~ll ,eteri,alion and angiography in any of the major vessels; co~o,1ary angiographic catheters which include the dirrerenl series of grouping including Sones, Judkins, Amplatz, multipurpose, and bypass graft c~tl ,eters; as well as many others developed for specific purposes and medical conditions.
Merely represe,1lali~re of guiding and controlling flexible catheters, generally presented herein without regard to their specific past usages or inlended applications, are those illusll ated by Figs. 1 and 2 respectively. As exemplified by the catheter of Fig 1, a catheter 2 is seen having a tubular wallof fixed axial length; having two ,c~roxilllal portals 4 and 6 which togetl,er generate the proximal end 8 for entry into the interiot of the catheter; a single distal portal 10 and the distal end 12 of the catheter; and an internal lumen 14 (which is not visible in the illusl~liGn).
Another variation commonly known is illustrated by Fig. 2 which shows a controlling flexible catheter 20 having a tubular wall of fixed axial length;
SUBSTITUTE SHE~T (RULE 26) W O 97/47261 PCTrUS97/09503-three proxi",al portals 21 22 and 23 respectively which collectively form the proximal end 24 for entry into the inter"al volume of the catl ,e~er and a single distal portal 25 which desiy"dles the distal snd 26 or tip of the ~U~eter. It will be appreci~ted and ~" Id~l~lood that Figs. 1 and 2 are ~l~resenled merely to show the overall y~neral construction and relationsh;p of parts presei~t in each flexible CGi'ltl ulling catheter suitable for use with the u, esenl " ,ethodcloyy.
In acco,dance with established principles of convenlional catheter construction the axial length of the caU ,eter may be composed of one or several layers in combination. In most multilayered constructions one hollow tube is sll etched over an~tl ,er to form a bond; and the cor,~pG"ents of the individual layers detel ,nine the overall ~;l ,aracleri~lics for the c~tl ,eler as a unitary construction. Most multilayered call1eler~ comprise an inner tube of teflon over which is anotl ,er layer of nylon woven Dacron or slai(lless steel braiding. A tube of polyethylene or polyu~ ~U ~ane is then heated and extruded over the two inner layers to form a bond as the third e~ter"al layer. Other calheter constructions may consisl of a polyurethane inner core covered by a layer of stainless steel braiding and a third external jacket layer formed of polyu, etl ,ane.
Several exa""~les of basic catl,eter construction and design are illus(,dled by Figs. 3-6 res~ecl,~ely. Figs. 3A and 3B are perspective and cross-se~tional views of a single tubular wall considered the sla,1dard minimum construction for a catl ,eter. ~igs. 4A and 4B are per~pedi~re and cross-sectional views of a thin-walled design for a single layer extruded cdtheter. In co""~arison Figs. 5A and 5B are perspecti~e and cross-sectional views of a standafd multilayered catl ,eter construction having a braided st~-inl~ss steel midlayer in its construction. Finally Figs. 6A and 6 are per~pecti~/e and cross-se-;tio"al views of a thin-walled design for a multilayered catheter with a braided stainless steel middle layer.
Catl ,eter~ are generall~ sized by e~tter"al and inte" ,al diam~ter and length. The inte, nal specifiad either by dia" ,~ler (in thousan~llhs of an inch or milli",eters or French). Many newer thin-walled catheter designs provide a much larger il,te",al lumen volume to exler"al dia",eter ratio than has been previously achieved this has resulted in catheters which can accol"",odate much more volume and allow the pAssA~e of much larger sized articles through the internal lumen. External diameter is typically expressed in SUBSTITUTE SHEET (RULE 26) CA 022~7989 l998-l2-09 French sizes which are obtai"ed by multiplying the actual diameter of the catheter in millimeters by a factor of 3Ø Conversely by traditional habit the size of any catheter in millir~et~ra may be calculated by dividing its ~rench size by a factor of 3Ø French sizes from 5-8 are currently used for diay, IOalic angiogra~lhy. For purposes of practicing the present invention it is also desirable that French sizes ranging from 4-16 respectively be employed unless other specific size require~enls are indicated by the particular application or circu~alances. In addilion bec~use of the variation between standard thin-walled and super high-flow cdlheler construction designs a range and variety of e)~ler"al and internal lumen diameter sizes exist. To de"~onsl, ale the conventional practice the data of Table 1 is provided.

Dual-lumen catheters.
A number of dirrere,)l dual-lumen calhelers are known today which differ in the size and spatial relationsl ,i~ between their individual lumens.
This is iltuallated by Figs. 7A-7D respectively which show dirrerent dual-iumen constructions for four calheters having similar or identical overall diameter (French) size.
As shown therein Fig. 7A shows a dual-lumen catheter 30 wherein a first external tubular wall 32 provides an outer lumen volume 34 into which a second i"te, llal tubular wall 36 has been co-axially positioned to provide an inner lumen volume 38. Clearly the construction of catheter 30 is a co-axial design of multiple tubular walls sp~ced apart and co-axially spaced but separate internal lumens of differing individual volumes.
In comparison Fig. 7B shows a second kind of construction and design by dual-lumen calheter 40 having a single external tubular wall 42;
and an centrally disposed inner septum 44 which divides the interior tubular space into two approximately equally lumen volumes 46 and 48 respectively.
Thus in this construction the dia",eter length and volume of inler"al lumen 46is effectively identical to the dia",eter length and volume of internal lumen 40, and both of these exist and are conlai,)ed within a single co~ llollly-shared tubularwall.
A third kind of construction is illustrated by ~ig. 7C and shows an alternative kind of construction and design to Fig. 1 5B. As seen in Fig. 7C
dual-lumen catheter 50 has a single external tubular wall 52. and contains an SllBSTITUTE SHEET (RUL~ 26) asy""net, ically positioned i"~r"al divider 54 which divides the interior tubular space into two unequal and dir~er~nl lumen volumes 56 and 58 (espec1ively.
Thus in this alt~r"alive construction the discrele volume of internal lumen 56 is markedly smaller than the volume of the adj~~ently positioned internal 5 lumen ~8; and yet both of these inte",al lumens 56 and 58 exist in are ~d; ~cently posilior,ed and are both cont~.n~-l within a CO"""OI ,Iy-shared single tubular wall.
A fourth construction and design for a dual-lumen catheter is se, lle~ by Fig. 7D which shows a ~tl ,eter 60 having a single e~t~rnal 10 tubular wall 62 of relatively large size and ll ,ichness. Within the "~at~rial sl l~ .sl~lce 68 of the tubular wall 60 are two discrele bore holes 64 and 66 ofdi~re(i"g dia",eters which serve as two inten,al lumens of unequal volume.
Internal lumen 64 is clearly the smaller while internal lumen 66 is far greater in spatial volume. Yet each inte" ,al lumen volume 64 and 66 is ~ cel ,l to 15 the other lies in parallel and follows the other over the axial length of the ~tl ,eter.
In general the tubular body of the ca~l ,eter is gel ,erally straight over most of its length and may have ~i~rerent bends or curves towards the distal end or tip. A ~presenlali~e illu~ll atio" of the distal end of a catheter is 20 illusl,ated by Fig. 8. The individual bends in the ~tl,eter are l,aclilionally called "curves"; and the terms "prir"ary secondary etc. " are a~plied to each addilional curve further away from the distal tip as is illusl, ated by Fig. 8.
Accor~lingly the primary curve 100 is followed by the seco"dary curve 102 which in turn extends into the Cdti ,eter body 104 g~"erally. The CdU ,~ter tip 25 106 is its most distal sey",e,lt. In ~ddition the catl,eter distal tip 106 may have any combinéaliol, of a single end hole 110 or an open distal end 108 and any number of side holes 1 10 1 12 which function as portals for fluids and gases exiting the distal end of the caU~eter.
ConvenliGnal practice perl"its a number of dirrerer,t distal ends or tips 30 which vary in design and appearance. Merely represenlali~e of these pe""itled and conve"lional v~, iances in distal end design for call ,eter~
generally are the distal ends of ventricular calheler~ which include: a "pigtail"
design and construction which has a curled-tip format and multiple side holes; the Lehman ventricular catl ,eter end which provides a number of side 3~ holes in dir~erenl places along the distal end; and the Gensini design which provides multiple side holes at varying angles. Accordingly for purposes of SUBSTITUTE SHEET (RULE 26) CA 022~7989 1998-12-09 W O97/47261 PCT~US97/09503-p~CtiCi(Ig the present repair methodology any construction of the catheter distal end whether having one or more curves or none; and whether or not there is more than one central portal for exiting the lumen or multiple side holes are all considered conventional variations in construction design. Any 5 and ali of these distal tip designs and constructions are lhererore deemed to be enco,n,c assed completely and to lie within the general ~tl ,eter scope of construction suitable for use with the present invention.

B. The Obturator The second requisite co"~pone"t part of the call ,eter apparalus is the obturator. Each embodiment of an obturator preferal,ly comprises four parts:
a puncturing headpiece; a pei foraling end tip on the headpiece; an elongated shaft integral with the puncturing headpiece; and means for expanding and cout~acting the size of the puncturing headpiece on-demand. Various 15 embodiments representative of each of these structural components are individually illusll aled within Figs. 9-15 respectively.
One prefer~ed embodiment of an obturator is illusl,aLed by Figs. 9-13 respectively. As seen therein the obturator 120 con,~rises a puncturing headpiece 122 which is s~ sl~nlially cone-shaped in configuration and 20 comprises an outer shell 124 and a base plate 126. The outer shell 124 has deterr"inable dimensions and a girth which can be altered in size. At the distal end 128 of the puncturing headpiece 122 is a pel roraling end tip 130 which appears as a cross- or star-sl1aped cutting edge for the headpiece 122.
As shown by Fig. 10 the pe"orali"g end tip 130 does not extend over the 25 entire surface area of the outer shell 124; instead the perrorating end tip 130 is limited in size and orientation to the distal end 128. The pe, rorali"g end tip 130 serves as the sharp cutting edge for the obturator 120 as a whole.
Integral with the puncturing headpiece 122 is an elongated shaft 134 whose overall axial length may be varied to acc~,nrnodate the surgeon and 30 the particular medical circumstances of usage. The distal end 136 of the shaft is irltegrdled with the puncturing headpiece 122 and provides access to the interior volume of the headpiece bounded by the outer shell 124 and the base plate 126. The proxi~al end 138 of the elGIlgdled shaft 134 is intended to be held by the surgeon or invasive radiologist performing the vascular 35 bypass surgery. Accordingly the axial length of the elongated shaft 134 will vary and acco" ,rr,odate the surgeon; and thus vary from a few inches to a few SUBSTITUTE SHEET (RULE 26~

W 097/47261 PCTrUS97/09S03 -, . .
feet in length. The function of the 010l Iyated shaft 134 is for the carrying and t, anspo, l of a previously ex~-ise :l v~sclJI-r segment to the cl)ose" site on the unobsl, ucted or primary blood vessel in-vivo. The elongaled shaft 134 acts to support n,ainlain and convey the excise~ v~scular segment within the 5 lumen of the catheler in a n,an,)er such that the V~SGI ~I-r seg",ent can be used as a bypass graft.
A critical requirement and feature of the puncturing I ,ead,~ ce 122 and the obturator 120 as a whole is that means exist for expanding and contracting the puncturing headpiece on~len~and. This requir~me, It and 10 ~I,dracte,islic is illusl,dted by Figs. 11-13 respectively. As seen within Fig.
11 the puncturing head~iece 122 appea,5 in its initial size identical to that shown by Fig. 9. The outer shell 124 is su~slanlially cone-sl,aped in configuration has an initial inte",al volume and has a girth di",el,sion d equal to the initial .Jia",eter of the base ptate 126. The internal volume of the 15 puncturing headpiece as detel",i"ed by the dimensions of the outer shell 124 and the base plate 126 provides an initial il llel l ,al volume of dete"".nable quantity.
When the n)ecl ,a"i3m for contracti"g the puncturing headpiece is activated the consequence is ill~lst,a~d by Fig. 12 in which the di",ensions 20 of the outer shell 124 are diminished and the girth of the headpiece has beenreduced as shown by the red~ced diameter d of the base plate 126. Note also that as the puncturing l~ead,~iece 122 beco"~es cont,acted in overall volume and di",ensions the configuration of the puncturing headpiece 122 has conse~- ~enlially become allered and now appears to be spear-like in 25 configuration. Similarly the overall angular di~posili~ " of the pe, ror;dling end tip 130 serving as the cutting edge will also be slightly altered in overall appearance as a co~,sequence of COI Itla~Aing the puncturing head,~iece 122.
Alle",ati~/ely when the puncturing he~dpiece 122 is ex~anded the overall result is shown by Fig. 13. As seen therein the outer shell 124 has 30 been e~,uancleJ in overall dimensio"s and volume; and the girth of the head,t~iece has been ex~a"ded and can be determined by the dia",eter d" of the e~-~,d, Ided base plate 126. Note that the overall appearance of the puncturing headpiece has been altered as a c~nsequence of its expansion and now appears to be elliptical in shape overall. Similarly the pe, rorali"~
3~ end tip 130 has similarly been altered in appeara"ce and has angularly SUBSTITUTE SHEET (RULE 26) CA 022~7989 1998-12-09 W O97/47261 PCTrUS97/09503-expanded somewhat to conro"" with the expanded di",ensions and angularity of the outer sheli 124.
It will be recognized and appreciated also that throughout the changes in appearance internal volume and overall size for the conl, acted or 5 expanded puncturing headpiece 122 as shown via Figs.11 12 and 13 res,cecli~/ely the dimensions and overall configuration of the 010ngaled shaft 134 have not been allered meaningfully or sigr,ificanlly. Although this is not an absolute requirement in each and every embocli."ent of an obturator it is pr~fer~ed that the eIOI ,yaled shaft 134 particularly at the inleyl dted distal end 10 136 remain consla"t in size and volume as much as possible and be unaffected subsequent to the on-demand ex~.ansion or contraction of the puncturing headpiece 122. This prerer~nce and feature will "~di"lain the ir~leylily and continued viability of the excised vascular seg",enl inten~Jed tobe carried and ll a"s~o, lecJ by the elongated shaft during the bypass grafting 15 proce-lure. Thus to avoid or minimize any physical damage to the vascular wall of the graft r"alerial it is most desir~ble that the elongated shaft be maintained in appearance configuration and dime,lsions without change whenever possible.
An essential feature and component of each obturator is the existence 20 and availability of specific means for expanding and contracting the puncturing headpiece on-del"~"d. A number of clirrerenl mechanis",s and means for expanding and contracting the puncturing headpiece of the obturator are convel lliol ,ally known and easily employed. Merely to de",ons~,ale some cJirrer~nl and convel,lionally known mecl,anis",s attention 25 is directed to the means illuslldled by Figs.14 and 15 respectively.
The means for expanding and co"l,a~iling the puncturing headpiece on-demand illu~l,dted by Fig. 14 co"slilute a mechanical ap~roach and design mechanism which is carried within the i"le" ,al volume of the puncturing headpiece 122 and the integrated elongated shaft 134. As seen 30 therein a central rod 150 extends through the hollow inlel ior of the elongated shaft 134 and extencls into the internal volume derined by the outer shell 124 and the base plate 126 of the puncturing headpiece 122. Within the internal volume of the outer shell 124 a plurality of rotabl2 ribs 152 are joined to the central rod 150 at the distal end to form a central pivot point 154. Each 35 rotable rib 152 is mobile and pivotable around the central point 154 and forms an umbrella-like scaffolding structure which can be expanded outwardly or SUBSTITUTE Sl~EET (RULE 26) E 0~ ~ u, E N ~ ~

tD

t ~-- _ o o o ~ E
. _ C o~ o c a)~ ~ E O C' C -C I D ~ o ~ ~
~ ~ ~ ~
o o O O

C O
E ~ ~ ''' m 3 ~ ~D
~ ~ O

~ ~
-- ._ ~ ~ b b ~~
~ U~
E

a) E ~ ~ ~ ~
E ~ c~i N N ~) E r~
~ . _ x _ c ~ r) 0 N 'J 0::~ c Y -- (D 1-- a~ o ~ ._ O O ~ ~ ~ ~D
- b b b b b ._ ~D
~D
-- ~D z D ~

SUBSTITUTE S~lEET (RULE 26) CA 022~7989 1998-12-09 W O 97/47261 PCTrUS97/09503-~a -collapsed inwardly at will. Mounted on the central rod 150 is an expansion wheel 156. This expansion wheel 156 is centrally mounted on the rod 150; is moveable over the axial length of the central rod 150; and is controlled in the direction of axial movement (distally and proximally). The expansion wheel 5 156 c~ rises a center hub 158 and a plurality of hub supports 160, both of which ",ainlain the expansion wheel in proper posilion as it engages the plurality of rotable ribs 152. Joined to the central hub 158 of the expansion wheel 156 are linear movement members 162 which are positioned within the interior volume of the elongated shaft 134 and have a length sufficient to 10 reach to the proximal end 138 of the elongated shaft 134 for control by the surgeon or invasive radiologist. The linear movement members 162 engage the center hub 158 of the expansion wheel 156; and extend or withdraw the expansion wheel closer to or away from the perforating end tip 130 of the puncturing headpiece 122. When the expansion wheel is engaged and 15 pushed forward, expansion wheel engages the rotable ribs 152 and expands the rotable ribs outwardly thereby increasing the overall girth of the puncturing headpiece as a unit. Alternatively, when the linear movement members 162 are withdrawn, the expansion wheel recedes towards the pro~in,al end and the engaged rotable ribs 152 collapse inwardly within the 20 volume of the outer shell 124. The consequence of this movement is a contraction of the puncturing headpiece 122 as a unit. It will be recognized and ap~,reciated that this mechanical a,c proach for expanding and col1lracting the puncturing headpiece is completely conventional in design and operation;
and accordi, lgly, any conventional refinement of these basic coi "ponent parts~25 is co,~sideled to be a variation within the scope of this mechanical system.
As a represe,~la~ed alternative, hydraulic means for expanding and cGr,l,acting the puncturing headpiece of the obturator on demand is also provided. In this system, as shown by Fig.15, the internal volume of the puncturing headpiece 122 and the integrated elongated shaft 134 includes an 30 elastic sack 180 comprised of a fluid containing elastic bubble 182 and a fluid delivering elastic conduit 184. The outer shell 124 and base plate 126 of the puncturing headpiece 122 are as previously shown; and the headpiece 122 is integrated with the elongated shaft 134 as previously described herein.
Within the internal volume of the puncturing headpiece 122, is a fluid 35 containing elastic bubble 182 which is in fluid communication with the elastic conduit 184 carried within the internal volume of the elongated shaft 134.

SUB~TITIJTE SltEET (RULE 26) CA 022~7989 1998-12-09 W O 97/47261 PCTrUS97/09503 -- ~ 3 -The elastic sack 180 is ro",led of elaslor"eric material (such as rubber elastic plastic and the like) and is fluid-tight along its seams. The elastic sack 180 contains any liquid which is co",~>ati~le with the ",~l~rial of the elastic sack; and it is the inll insic nature of the material rormi. ,g the elastic 5 sack 180 that the mdt~rial exerts a cor"pressio(, force or pressure upon the fluid conlained within the elastic sack itself. In this way a hydraulic system for expanding and conl,d.;ling the puncturing headpiece of the obturator is created.
As fluid is intro~luced through the elastic conduit 180 by the surgeon or 10 invasive radiologist that fluid is conveyed and delivered into the elastic bubble 182 posilioned within the puncturing headpiece 122. The elasticity of the bubble 182 exerts a mild co",,~ression force and pressure againsl the quantity of fluid conlain~J within the bubble interior volume; acc~rdin~Jly the yl ealer the quantity of fluid within the elastic bubble 182 the larger in overall ~5 volume the elastic bubble beco,),es. Thus as more fluid is delivered through the conduit 184 into the elastic bubble 182 the larger in overall volume the elastic bubble l,ecomes; and as the volume of the elastic bubble e,.~.~n.ls the overall configuration and internal volume of the piercing headpiece 122 also enlarges. In this ",ar",er by carefully controlling the amount of fluid 20 conveyed through the conduit 184 into the elastic bubble the overall size andconfiguration of the piercing headpiece 122 can be controllably ex~anded.
Subsequently to reduce the overall size and configuration of the puncturing headpiece 122 a quantity of fluid is pen"itled to be released from the elastic conduit 184 at the pro,~i",al end by the surgeon or radiologist. Bec~ ~se the 25 i"ate,ial is elastic and exerts a co~pression force against the quantity of fluid ~res~"t within the bubble at any given ",ome"l in time the release of fluid through the elastic conduit will cause a reduction in overall size for the elastic bubble 182; and as the overall volume of the elastic bubble is red~ ~ced in size the puncturing headpiece will consequently be contracted and reduced 30 in configuration and overall volume as well. It will be noted and appreciated also that this hydraulic mechanism for e).~andiny and cont, acting the puncturing he~driece on d~ma"d is a convel ,liu"ally known fluid system and techniq.1e; and many conventionally known va, iations and c~anyes in hydraulic design and fluid control systems are presenlly known and 35 comr"or,ly available for use. Accordingly all hydraulic systems are SUBSTITUTE S~IEEl (RULE 26) CA 022~7989 l998-l2-09 W O 97/47261 PCTAJS97/09~03-_~y_ envisioned as suitable for use as one means for exlJanding and col1l(acti,1g the puncturing headpiece of the obturator on~e,l,and.
A number of dirrere, It physical e,llbodi",ents for the obturator are also envisioned and intended for use. Some examples, which are merely 5 illustrative of the range and variety of physical fom,a~s and which serve to merely illustrate the range and ~legree of dirrerence available for the various puncturing headpieces of an obturator, are illustrated by Figs. 16-22 respectively. It will be recognized and understood, however, that these allel "ali"e er,lbodi",ents are merely re,uresenlalive and illustrative of 10 obturators and puncturing headpieces generally and do not signify any limitation or restriction on their structural construction or design.
The embodiment illusllated by Figs. 16 and 17 respectively shows a puncturing headpiece 200 which is su~slanlially cone-shaped in overall appearance and comprises an outer shell 202 and a base plate 206. The 15 distal end 208 of the puncturing headpiece 200 has a pel roraling end tip 210which is also substantially cone-shaped in configuration and appeara"ce and covers only a small surface area of the outer shell 202. Integral with the puncturing headpiece is the elongated shaft 134 as described previously herein; and means for expanding and cont~acli ng the puncturing headpiece 20 200 on-demand are included within the obturator as a integrated unit.
Another embodiment for the puncturing headpiece is illustrated by Figs.18 and 19 respectively. As shown therein, the puncturing headpiece 220 cG"".rises the outer shell 222 and the base plate 224 integral with the elongated shaft 134. A particular feature of this embodiment, however, is the 25 distal end 226 seen most clearly within Fig.19 as providing a pel roraling end tip 230 which is substantially star-shaped and extends over the surface area of the outer shell 222. The result is to provide a series of grooves 228 alternating with sharp cutting edges 232 over the surface of the outer shell 222. This embodiment for the puncturing headpiece 220 provides a much 30 ~redler area for cutting and pel roraliol1 as a specific feature of the obturator design.
To demonstrate further the variety and degree of differences envisioned and in~ended when constructing a puncturing headpiece, the structural constructions exemplified by Figs. 20-22 respectively are provided.
35 As illustrated by Fig. 20, the puncturing headpiece 250 includes a buttressing region 254 as a part of the outer shell 252. The buttressing region 254 is a SUBSTITUTE S~IELT (RULE 26) CA 022~7989 1998-12-09 W O 97/47261 PCTrUS97/09503-- ~ 5-r~;. ,ro,.;ed region for engaging and bel ,ding ",dlerials placed in conta~ withthe outer shell when the puncturing head~iece is ex~Jar,ded. The puncturing headpiece 250 inc~- ~des a base plate 256 and is integrated with the elongaled shaft 134 (described previously herein).
In cc:""~a,ison the puncturing hea~,iece 260 exe",pliri~.J by Fig. 21 is a sharply tapered and contoured embocl""enl in which the outer shell 262 includes a spiral girth zone 264 suitable for derorl,~ing elastic ",at~rials. The base plate 266 conror",s to and is inleyldled with the spiral zone 264.
Another aller"dti./e embodi",ent of the puncturing headpiece is illustrated by Fig. 22. In this embodiment the puncturing headpiece 280 co",,~" ises an outer shell 282 and a concave-sl~a~,ed or scalloped zone 284 which is joined to and integrated with the base plate 286. The concave-shaped configuration of the zone 284 is inle"ded to aid the puncturing he~drioce as it is ex~.at~decl and cor,l,ac~ed on-de,~and.
C. The Defor",able Cuff A requisite col"pol ,ent part of the c~tl ,eter ap,~a~tus for credli"g a vascular bypass graft is the presence and use of a deformable cuff or flange such as is ill~J~trated by Figs. 23 and 24 respecli~/ely. As illustrated and embodied therein the defor" ,able cuff 300 is a substantially cylind~ ical-shaped collar which is open at each of its ends 302 304. The cuff 300 is hollow; is s!lh5lZ~l ,l;ally round or oval (in cross-sectional view); and has dete""inaLI~ dimensions initiallywhich can be de~u,,,,ed atwill when sufficient force is applied to the sidewall 306. As an aide in controlling the intended .lerol",dtion of the sidewall 306 on-de",d"d via the i"lenliooal application of exle,r,ally applied forces1 it is most desi~dble that the material constituting the sidewall 306 of the cuff 300 be pre-stressed along the axis M' as shown within Fi~. 23; and that the malerial cGnsliluting the sidewall 306 be an open-weave pdllern of resilient matter rather than take form as a so~id mass of r"alerial. For this reason the sidewall 306 illl,sl,aled within Fig.
23 appears as an open meshwork of wires 308 which are intertwined to form a s~ sln~ Itially l ,exAgQnal pdtler". This open meshwork of wires 308 provides the desired resiliency fiexibility and defor",dlion capability (particularly along the axis M ) such that the upper portion of the sidewall 306 can be defor"~ed and flaired outwardly on-de" ~a"d to yield the flaired-lip deformity 310 shown by Fig. 24.

SUBSTITUTE S~EET (RULE 26) CA 022~7989 1998-12-09 W O 97/47261 PCT~US97/09503-~a~-lt will be recognized and appreciated that the deform cuff shown by Fig. 24 is merely the result and consequence of exerting force alon~ the u,~ per,~,osl portion 309 of the open meshwork of wires 308 above the axis M
such that the upper sidewall 309 adjac~,)l to the open end 302 has become 5 expanded outwardly flaired and bent into a curved lip configuration in the derol ",ed state. Note that the open meshwork of wires constituting the lower portion 307 of the sidewall 306 at the other open end 304 remains relatively stable and s!~hst~ntially unaltered in its original shape and state. The dero~ llldLion has thus been CGI 1ll olled and the forces applied only to the upper 10 portion from the AA axis to cause the outwardly extending flaired lip result.Moreover the resulting flaired lip zone 310 retains structural sller,yll, and resiliency as an open meshwork of wires despite having been created by d~ro""alion. The ability of the cuff to be dero" "ed in the manner illustrated by Figs. 23 and 24 ~especti~rely is a requisite and necessa"/ attribute and 15 characte~islic of each e",bodi",elll and construction for the def~"nable cuff.
The construction and design for the deforlnable cuff in the present invention is an example of the e, ~ginee, iny principle that structural form follows intended function. As a requisite component part of the catheter apparatus and methodology for cr~dli, ~g a vascular bypass in-vivo the 20 intended functions of the deformable cuff are twofold in nature: (1 ) the de~or"lable cuff is intended to engage and become ~oined to a previously excised vascular segment which will serve as the bypass graft in-vivo; and (2) the ~efGr",ablc cuff is intended to be positioned within the i"ler"al lumen of an unol,sl,ucted major blood vessel (such as the aorta) and beco",e 25 ~leror",ed in-situ such that a portion of the cuff becomes positioned and secured to the internal lumen (the blood flow channel) of the unobstructed blood vessel permanently and in a fluid-tight manner. Thus as illustrated by the embodiment of Figs. 23 and 24 the upper",ost region 309 of the cuff 300 is deror",ed on-demand into a flaired outwardly bent form which is intended to 30 be secured within the lumen of the unobstructed artery or vein while the undisturbed sidewall portion 307 of the cuff is intended for engage",ent and juncture to the previously excised vascular segment which will serve as the bypass graft. However because there is no specific pre-positioning or pre-alignment of cuff sections or portions as to ultimate or inlended usage it is 35 ir"material and irre~evant structurally as to which end of the deformable cuff serves which intended function and purpose.
SUBSTITUTE ~HEET (RULE 26) CA 022~7989 1998-12-09 W O 97/47261 PCTrUS97/09503-- ' --.?q--Several attributes and cl ,aracterislics are con""ollly to be shared among all embodi",enls and constructions of the deformable cuff. These include the following:
(a) It is only required that the material con~liluting the cuff be 5 ~leror"~able on~",a"~. For convenience and g,edler facility in achieving such de~""ily in the degree and at the time required it is most desirable that the material rorl"ing the cuff be an open weave or meshwork rather than a solid mass which is considered to be more difficult to deform in a controlled manner. There is however no resl~ i~tion or li~ilalio" at any time or under any 10 intended use circulllsta"ces which necessilates an avoidance of a solid mass of material either as a single sheet or as a la".inated plank of malerial.
Accordingly the choice of whether to use an open meshwork or a solid mass of ",aterial is left solely to the ~iscretiol) of the manufacturer and the surgeon.
(b) The defo",)able cuff need only be co",~, ised of resilient 15 flexible but defo,mablc matter. A number of difrer~nl cG",positions and formulations of material may be usefully employed when making a de~r"~abl~ cuff suitable for use with the present invention. Among the desirable materials are those listed within Table 2 below.
(c) After the derorl"able cuff has been manuf~ctl~red using resilient 20 ",ale,ials the completed cuff structure (prior to defor",dlior,) may be .
subsequently covered to advs"lage with one or more biGcori,palible coatings.
These bioco",pdlible coalings are inlended to water-tighten the article and to faciîilale the seY:in9 of the e~c,sed v~scl~!~ sey",erlt to the cuff as well as to reduce the inleractiGns of the immune system with the vascular bypass graft 25 after it has been secured to the blood vessels in their appropriate localionsin-vivo. Such biocompdtil~lE coalings are conventionally known; will reduce the severity and duration of immune reactions which frequently disrupt or int~r~le with v~scul~r bypass grafts; and are co"siclered desirable in a majority of use instances in order to ~"ini",i~e the body reaction to v~scl ll_r30 bypass surgery. A represe"lali~e listing of biocompatible coatings deemed suitable for use with the defor"~aLI~ cuff is provided by Table 3 below.

SUBSTITUTE SHEET (RULE 26) W O 97/47261 PCTrUS97/09503--~8-Table 2: Deformable Materials Metals and Alloys stainless steel;
nickel/titaniuim alloys;
aluminum/nickel alloys; and graphite carbon and metallic blends of carbon Svnthetic Polvmers polyamides such as nylon;
polyacrylates such as polyacrylic acid;
polycallJoi~dles such as poly[2,2-bis (4-hydroxyphenyl)] propone; and polysiloxones.

Table 3 Prosthetic Coatings High temperature pyrongen-free carbon;
polytetrafluoroethylene (PTFE) and other polyhalogenated carbons;
Fibronection;
collagen;
hydroxyethyl methacrylates (HEMA); and serum albumins.

SUBSTITUTE SI~EET (RULE 26) CA 022~7989 1998-12-09 --0~ 9--(d) Although the e"lbo.li",ent of the cuff or collar prior to dero""alion exemplified by Fig. 23 appears as a geometlically regular and col)erent structure there is no requ"e",ei ,t or de"~and that either the structure or configuration of any deformable cuff c~r,ro"" to these 5 par~",et~rs. Accordingly it will be recoy"iced and ~" ,derslood that the defo",~able cuff structure need not be a co,~,plately el~cir~ling band or collarof dero""able ",~terial. To the cont,~ry a U-sl,ap~d band orflange of r"alerial where the sidewall does not overlap or join and where a gapped disla"ce separales the arms of the band or flange is both pel ",illed and 10 envisioned. Moreover although the cylindrical-shaped format of the defor"~able cuff illuslraled by Fig. 23 is highly desirable there is no requ,~en,ent that the ~Jian,eter of the cuff prior to clefor",alion be conslan~ or co"sistent over the entire axial length of the cuff when manufactured. Thus anisotropic cuff structures as well as isot.upic constructions are inte, Ided and 15 desirable. In this ",anner the cuff in its initial state prior to deformation may have a variable internal diar,)eter over the axial length of the article in which one open end may be either y~ealer or lesser in size than the other open end;
and there may be multiple increases and decreases in diameter size sl~ccessively over the entire axial length of the cuff itself. All of these 20 variations in construction and structure are within the scope of the present invention.
To illustrate some of the modesl varidliu,~s and dirrere,lces available and envisioned for a dero,lllabla cuff i,lte"ded for use with the preser,t invention the alLer"dlive cuff ernbodi",etlts ilh.sl~aled by Figs. 25 26 and 27 25 are provided. As shown within Fig. 25 the defor",able cuff or collar 330 appea,:~ as a cylin.l~ical-sl,aped article having two open ends 332 334 and a rounded sidewall 336. The body of the sidewall 336 is an open meshwork of closed loops 338 each closed loop being joined at multiple points along its peri",eter to at least one other closed loop -- thereby fG, I)~ 9 an open grid 30 meshwork. A notable feature of the cuff construction within Fig. 25 are the outer edges of the open ends 332 334. Each edge 340 342 is fo",)ed by a closed loop which is far more easily bent and derolllled than the closed-loop meshwork in the middle of the sidewall 336. In many ir,slances the availability of closed-loop edges 340 342 provide an e"or",ûus benefit and 35 adva"iaye in de~-",i"g the cuff in-situ within the internal lumen of an unobsl, ucted artery or vein. In addition the defor",able cuff 330 has been SUBSTITUTE S~EET (RULE 26) CA 022~7989 l99X-12-09 pre-stressed substantially at the midiine along the axis BB such that the upper most portion 339 of the cuff near the open end 332 and the edge 340 are more easily cJero""ed and flaired outwardly as a consequence.
A third embodiment of a defor",able cuff or flange is iliuslraled by Fig.
5 26. As shown therein the defo",~ble cuff 360 is fo",~d primarily as a series of coiled wires whose overlapping and inle~sec~ing portions have been fused together to make a unitary article. The defw"1able cuff 360 thus has the two open ends 362 364 and an open coiled sidewall 336 fo,-"e~ from the cor,lnlonly fused coits of wire. The open lattice work of coiled wires 368 10 provides the flexible and resilient meshwork suitable for achieving the primary functions of the defor"ldble cuff. Again the sidewall 366 has been pre-stressed along the axis CC such that the upper most portion 369 can be bent and ~lefor"led outwardly on demand using an expansion force.
Finally a fourth alternative e",bodi",ent is provided by Fig. 27 in which 15 the de~rn~able cuff or band 380 is shown having tv,/o open ends 382 and 384. In this instance however the sidewall 386 is comprised of a solid sheet of material. Two features are included in this embodiment of the deformable cuff due to its construction using a solid sheet of resilient material as the sidewall 386 for the cuff. The sidewall 386 has been pre-scored to form 20 cross-hatched squares over the axial length of the sidewall; and the pre-scored sidewall thus will deform far more easily and bend outwardly as shown when a e)~a"sion force is applied to the interior of the cuff. Similarly the sidewall material has been pre-~l(essed along the axis DD such that the upper most region 389 nearest the opening 382 will bend far more easily and 25 in a controlled fashion when and as required by the user.

Il. The Excised Vascular Segment To Be Used As A Bypass Graft The prefer~ed sources of blood vessels suitable for use as a vascular 30 bypass graft are the saphenous veins. These veins constitute the superficial veins of the lower extremities and comprise both the greater (or long) saphenous and the lesserl (or short) saphenous veins. Anatori)ically the long saphenous vein begins on the medial side of the foot and ends in the fermoral vein below the inguinal li~amenls; and the short saphenous vein 35 begins behind the lateral rnalleous and runs up the back of the leg to end inthe popliteal vein. However if the saphenous veins of the particular patient SUBSTITUTE SHEET (RULE 26) CA 022C,7989 1998-12-09 are unsuitable or unavailable for any reason~ either the cephalic or the basilicveins are very accept~hle substitutes for use as a v~-scul~r bypass conduit.
However, if these leg or arm veins are not available, synthetic or other biologic ",vler;31s may also be used as substitutes.
The medical procedure to isolate and excise the saphenous vein of choice is conve"lionally known and co"si~lered a routine surgical tect ,r,ique.
The sa,vhenous vein is harvested under ge"eral ane~lhesia. An incisiGn is first made in the medial malleolus, where the saphenous vein is often dilated.
The saphenous vein is identified and then dissected with a single incision made along its course with scissors. Branches are doubly clal"ped with he",oslatic clips and divided. The sa,4henous vein is then freed up and removed from the leg. The leg wound is closed with suhcl ~t~neous sutures and Ste, i~ll i,v adhesive over the incision. The vascular segment is prepared on a separale sterile table with adequate light and loupes, and branches are selectively ligated with 4-0 silk. An oval-tip needle on a syringe is inse~led into the graft to gently dilate it by administering a balanced electrolyte solution (pH 7.4, chilled to 7 to 10 C) and 10,000 units/liter of heparin. A
valvulotome is inse, led into the vein graft segment and the valves clipped with a 3-mm right-angle stainless steel instrument with a highly polished ball tip on the right angle. The knife edge is ,urotecled and sharply splits the cusp, causing valvular i"co",pete"ce. Measurements for the approxin,ale lengths of the grafts may be made with umbilical tapes, and the appropriate ler,!Jtl Is may be chosen before it is sewn to the cuff and coroual y arteries.

Ill. TheIntroducer~.y;.t~
The introducer system comprises the catheter alJpaldlus including the defor")able cuff and a previously excised vascular sey",enl in c~",b.. ,dtion;
and it is this introducer system which is utilized by the surgeon to perform therequisite acts and manipulalions by which the excised v~scul-r sey"~el ,l is 30 delivered to and bec~mes secured within the lumen of the unobsl, ucted major blood vessel (and subsequently ana~omosed to the obstructed blood vessel at a site distal to the obstruction). For des~ live purposes and for i"creased clarity of co",,l~rel-ension, this desc,i~,vtiol, will inlenlionally limit itself to the use of the obturator illustrated by Figs. 9 and 10 respecti~/ely, to the 35 deformable cuff construction and structure illuslraled previously by Figs. 23and 24 respectively, and to the use of a previously excised vascular segment SUBSTITUTE SHE,LT (RULE 26) PCTnUS97109503---3~ -taken from the long or short saphenous vein in the same patient. ~he introducer system represenls and provides for the intenlional place",el1t and carriage of the excised v~scl~a- s~ylllenl on the obturator the ~-yage,ne"~
and juncture of the def~r,)lable cu~f to one end of the excised vascular se~ment; and the proper orientation of the then engaged .leror",~ble cuff/excised vascular seymei)l on the obturator with respect to its relalio,1ship to the puncturing headpiece.
The formation of the introducer system begins with the proper plac~l"ent of the previously e~cised v~sc~ r segment (taken from the saphenous vein previously) upon the obturator. This manipulation is illustrated by Fig. 28 in which the excised vascular segment 400 is placed upon the elongated shaft 134 a~jacenl to but ~l ererably not in direct contact with the base plate 126 of the puncturing headpiece 122. As shown therein it is in~ended and prererl~d that the elongated shaft 134 will be inserted into the internal lumen 402 of the excised vascular segment 400 at the proximal end 138 held by the surgeon; and then the body of the vascular segment 400 is conveyed over the axial length of the elong~ted shaft 134 until a chosen position typically 1-2 centimeters from the distal end adJacent to the puncturing headpiece 122 is reached. In this manner the weight and body of the excised vascular segment 400 is carried on the elongated shaft 134; and it is desireable that the diameter of the elongated shaft 134 be only slightly smaller than the average dia~eter of the i"ler~,al lumen 402 for the vascul~r segment 400. As a consequence7 the excised vascular segment is ~degu~tely supported carried and transported by the elongated shaft during the entirety of the manipulations prior to entry into the body of the living patient as well as subsequent to the in-vivo pel r~r~lion of the unobsl~ucted major artery or vein.The manipulation illustrated by Fig. 28 is expected to be performed by the surgeon immediately after excisi"g the vascular seg"~ent from the patient but prior to beginning the bypass graft surgery itself.
After the excised vasc(ll~r segment 400 has been properly positioned on the elongated shaft 134 of the obturator 120 the defor"lable cuff (illustrated by Fig. 23 and desa iL.ed in detail previously herein) is desirablypassed over the puncturing headpiece 122 and over the open end 404 to cover a small portion of the exterior surface over the excised vaSCUl~3r se~me"t 400. It is desirable (but not absolutely necessary) that a gap distance (about 1-2 centimeters) separating the open end 404 from the SU~STITUTE SltEET (RULE 26) CA 022~7989 1998-12-09 puncturing headpiece 122 be r"ainlained during the placement of the defor",dL,I~ cuff -- as this will allow for easier posilior,i"y of the derorn,able cuff in a pre-chose" aliy"l"el,t and posture and a more controlled defoln)alion on-derl,a,)d. Once the defor",alJle cuff 300 has been posilioned over the v~sclJl~r sey",el " to the sAIisr~ 1iGn of the surgeon the lower regionof the cuff covering the end exte, ior surface of the excised v~sa ~I? seglnent 400 must be enyay~d and l.ecor"e joined to the v~sc~ seyl,)enl in a reliable and safe ",anner.
One prefel ,ed manner of er,ya~~el"er,l and juncture is for the surgeon to suture the open meshwork sidewall of the cuff directly to the v~scl ~'-= wallof the excised seyll~e,)t. This suturing is easily pe"v,llled by the surgeon prior to beginning the grarli"y surgery and the sutures 420 will serve as the physical means for engaging and ~ue""allenll~ joining a portion of the open meshwork of wires in the sidewall of the cuff to the excised v~-scl ll-r segmentitself. The type of sutures 420 their place" ,e"t their number and the linkage to the vascular wall of the excised segment are left to the pe, ~onal disc~etionand choice of the surgeon.
Other means for engaga"~enl and juncture of the defor" ,able cuff to the v~scu~-- wall of the excised sey",ent also are COIlllllOnly available.
These include surgical staples; L.iocG""~alible aJl,esives; enci~cling ligatures;
and a wide range of fasleners and closures. Any and all of these allel "ali~es may be employed alone or in co"lbination to achieve a reliable el~gagel"enl and juncture.
After the defor",able cuff has been engaged and joined to one end of the excised vascular sey",enl then carried upon the elongated shaft of the obturator the size of the puncturing headpiece 122 should be adjusted in shape and girth such that the dia",eter of the base plate 124 of the puncturing headpiece 122 prererably is equal to or slightly y,ealer than the diar"eter of the open end 302 for the defo""able cuff 300. This manipulation is also illustrated by Fig. 29 where the size of the base plate 126 is coeAlensive in diar"eter with the dia",eter of the open end 302 of the rur",able cuff. In this preferred manner the entirety of the puncturing l)ead~.ece 122 serves as a front se~;tion or first stage for the introducer system as a whole.
The wr"ple~e introducer system is illustrated by Fig. 30 in which the fully prepared obturator carrying the previously excised vascular segment to SUBSTITUTE Sl IEET (RULE 26) CA 022~7989 1998-12-09 W O97/47261 PCT~US97/09503 y_ be used as a bypass graft and the deror,l,able cuff have been positioned in advance; and the prepared obturator placed within the internal lumen of a cdll ,eter. As seen lher~7in the calheter is exposed in cross-sectional view and shows the hollow tube 2 of fixed axial length having a disclete ~,r~xi,l,al 5 end (not shown) a discrete distal end 10 and an inler"al lumen 14 of pre-deten~ined diameter sufficient to house the entirety of the prepared obturato (illusl,aled by Fig. 29). The distal end tip of the catheter is adapted for guidance of the c~tl ,eter in-vivo to a ci ,osen site where an Ul ,obslr~cted artery or vein is in anatomic proxi",ily to an obstruction Iying within another 10 blood vessel; and the prepared obturator of Fig. 29 (including the previouslyexcised blood vessel sey",enl 400 and the deror"~able cuff 300) has been placed into the internal lumen of the calheter. The introducer system is now complete. As shown by Fig. 30 the surgeon may now begin the first steps for surgically delivering the introducer system into the thoracic cavity or other 15 a~,uropriate body region in order to create the vascular bypass graft.

IV. The Routing And Surgical Introduction Of The Cc.~..lling Catheter Into The Body Of The Living Human Catheleri~dlio" involves a great deal of technical skill some 20 instrumentation and mature judy,l~ent in order to choose among the appropriate procedures and the various techniques which are now conventionally known and available for use. Clearly because the present technique conslilutes catheter intervention in critically ill palie"ts the physician or surgeon must be very familiar with the available a"alor"ical 2~ allel "ali~es in order to select the best routing for introducing the call ,eter the best technique in order to ~Gcess the thoracic cavity of the body where the obstructed artery and aorta exist and to carefully select the timing and other operative conditions in order to achieve best results.
In general catheterization can be performed using any duct tube 30 channel or p~ss~geway occurring naturally or surgically created for the specific purpose. Thus among the naturally occurring passageways in the body are the anus; the alimentary canal; the rnouth ear nose or throat; a bronchus of the lun~; the urethra; the vaginal canal and/or cervix; and any blood vessel of sufficient size of the central circulation in the body. Any of 35 these routings are envisioned and expected to be used when and if appropriate. However clearly a co,n",only used and the critical route of SUBSTITUTE SHECT (RULE 26) CA 022~7989 l998-l2-09 Access is the introduction of ~tl ,eter~ into the thoracic cavity and the arterial blood circ~ tion A-l; cent to the heart.
For this reason it is useful to briefly sullllllal i~e the tecl ",i~ue currentlyin use for introduction of catheters into the central blood circu!-~ion as an 5 illustrative exar"p e of pref~r,ed ~tl,eteri~ation teol,ni~lues. There are twog~ner~l m~ll ,Gds currently in use. These are: (a) percutaneous introduction using needles and guidewires; and (b) direct introduction after surgical isolation of the blood vessel of choice. While either yener~l ",etl,od may be utilized at any site of the general circulation pradical and anatomical 10 considerali~ns including the site of the flawed tl~erapeutic a~.pliance wil s~enerally dictate which approacll is most ap~.ro~riate under the individual circu" ,slances.

The modified Seldin~er Techni~e:
The percutaneous introduction of a cdtl,eter is illusl,aled by the modified S~ldinger technique which is shown by Figs. 3~A-31 F respe.ti~ely.
Fig. 31A shows a blood vessel being punctured with a small gauge needle.
Once vigorous blood return occurs a flexible guidewire is placed into the blood vessel via the needle as shown by Fig. 31 B. The needle is then 20 removed from the blood vessel the guidewire is left in place and the hole in the skin around the guidewire is enlarged with a scalpel as shown by Fig.
31 C. Subsequently a sheath and a dilator is placed over the guidewire as shown by Fig. 31 D. Tl ,eredrler the sheath and dilator is advanced over the guidewire and directly into the blood vessel as shown by Fig. 31 E. Finally 25 the dilator and guidewire is removed while the sheath rel,lains in the blood vessel as illuslraled by ~ig. 31 F. The catl ,eter is then inserted through the sheath and fed through to reach the desired location.
The other general n~etl ,od for the introduction of catl ,eters into the blood circulation is a direct surgical cutdown. The surgical cutdown approacl, 30 is generally less favored and is typically used for the brachial or fei~,orala~.p~acl ,. Cutdown ~rucedure is often a complex surgery and is used only when no direct ~ccess is ge"erally available. A far more complete and fully des~;, iptive review of both these general cdtl ,eteri~alion techniques is provided by the texts of: Dia~noslic And Therapeutic Cardiac 35 Catheteri~dlion secondedition 1994 Chaptereight pages90-110andthe references cited therein.

SUBSTITUTE SHEET (RULE 26) CA 022~7989 1998-12-09 W O97/47261 PCTrUS97/09503-Accordingly, for purposes of practicing the present methodology, any and all conventionally known genaral cathete~i dliGn procedures and tecl " ,iq~Jes which are convenli~nally known and in accor~a"ce with good medical pracLice are explicitly intended to be utilized as necessary in their 5 original format or in a ",odiried form. All of these general catheteri~atio,l routing and use techniques are thus envisioned and are deemed to be within the scope of the prese"~ invention.

General rules for choosin~ an apPl opriate site of body entry:
An axio",dlic or general set of rules by which a surgeon or radiologist can chose a proper or ap,cropriate site of entry for introducing the guiding calheter into the body of a patient for purposes of creating a v~scl ll_r bypassin-vivo is as follows: (a) always pick the shortest and straightest pathway possible or available; (b) identify the chosen entry site on an existing and accessible unobstructed artery or vein, the larger the diameter of the unobstructed artery or vein the better; and (c) identify the location and orientation of the obstruction in the obstructed artery or vein and chose an entry site distal to the obstruction.

A favored a~ roacl, to introducin~ the ~uidinq catheter into the thoracic aorta:Using the ascending aorta appruacl, as a representalive illu~l,alion and example:
(1 ) Under ge"eral anesthesia, the chest of the patient is prepared and draped in a sterile fashion.
(2) A three-inch incision is made to the left or right of the breast bone through which the surgeon operates.
(3) Three additional one-inch incisions then are made to insert a video camera, knife, surgical stapler, and other instruments.
(4) The ribs are separated, the thoracic cavity is entered, and the asce"dir,s~ thoracic aorta is exposed.
(5) The introducer system is then positioned at the chosen site on the ascending thoracic aorta.

SUBSTITUTE SI~EET (FtULE 26 CA 022~7989 l998-l2-09 3~
V. The In-Vivo Pla~ t Of The Vascular Bypass Graft Into The Lumen Of The Unobstructed Major Blood Vessel The method of the present invention utilizes the introducer system via 5 the catheteri~dlion tech"i~ue to create the v~c~ bypass graft between a major u(lobsll ucted blood vessel such as the aorta and an obstructed blood vessel in-vivo using a previously exc~sed v~scul~r segment as a conduit.
This p~cedure is illusllaled by Figs. 3241 collectively. It will be and a~ preci~ed, however, that while Figs. 32-41 exemplify and illustrate the 10 manipulations of the surgeon and the events in sequence leading to the creation of a vascular bypass, this desc,ipLion and the figures lllelllselves present a greatly simplified presenlaliol) and explanation of the medical proce.Jure, the techl)ical skills required, and the safety measures taken for the patient's benefit medically.
After the controlling calheter has been routed and surgically introduced into the body of the living human in the Illall,ler clesclibed previously herein, the first critical stage for the process is reached as shown by Fig. 32. The illuatlatioll of Fig. 32 (as well as Figs. 33-41 respectively) are shown as partially exposed views in order to show more easily the detailed place"lent and orientation of the prepared obturator carrying the derorlllable cuff and previously excised v~scul~r segment in combinaliol ,.
As seen within Fig. 32, the major artery such as the aorta 500 is shown in partial cross-seclional e)~,osed view to reveal the thickness of the arterialwall 502 and the inle" ,al lumen 504.
The catheter and the prepared obturator are as desol il,ed in detail previously herein and illustrated by Fig. 30. It will be noted that the puncturing headpiece 122 of the obturator 120 is positioned within the lumen of the ~theter 2 such that the pe~ roralirly end tip 130 is in direct conlact with the arterial wall 502 at the c hosen vAsc~ site. The puncturing headpiece 122 is of sulrlci.~"l size such that the entirety of the de~oll,l~ble cuff 300 and the joined V~SCIJ~-~ seylnent 400 lie directly behind and are in axial alignmentwith the puncturing headpiece 122 and the el~l lgaled shaft 134. When positioned as shown by Fig. 32, the prepared obturator is properly placed for piercing and penel(ating the arterial wall on-demand.
When the surgeon extends the pre,~ared obturator within the internal lumen of the catlleter 2, the result is illusl~aled by Fig. 33. As seen therein, SUBSTITUTE SHEET (RULE 26) CA 022~7989 1998-12-09 W O 97147261 PCT~US97/09503--3~-the pe, ~or~li"~ end tip 130 has pierced and punctured the arterial wall 502 and been advanced into the arterial lumen 504. The initial hole in the arterial wall 502 made by the pe, ror;aling end tip 130 is widened into a passageway as a consequence of the puncturing headpiece 122 following the entry path created by the pe, rorali~ ~y end tip. As the puncturing headpiece 122 penetrates the arterial wall 502 the size of the puncture in the arterial wall becomes widened and enlarged to col,ror") to and accol"",odate the configuration and the girth of the puncturing headpiece in its entirety. The configuration and overall size of the puncturing headpiece 122 thus serves as the means for widening the initial puncture made by the pe, rorati, lg end tip 130 such that the entire girth and overall diameter of the o~turator (complete with the defor,nable cuff and excised blood vessel segment in cor, lbi"alion) can subsequently pass through the e,1larged hole in the arterial wall.
As the prepared obturator is extended further across the thickness of the arterial wall 502 through the enlarged passage the pen~t,a~ing headpiece 122 is extended farther into the arterial lumen 504 until at least theupper portion of the dero""able cuff 300 has advanced far enough such that the cuff 300 has itself entered the internal lumen of the blood vessel. This sequence of events and result is illustrated by Fig. 34.
Subsequently after the upper portion of the deformable cuff 300 has advanced into the arterial lumen 504 the surgeon holding and controlling the proximal end of the catheter (not shown) activates the means for co, ll~ dC~il Ig the girth of the puncturing headpiece 122 while the headpiece lies extended in the arterial lumen 504. This manipulation and result is illustrated by Fig.
35. As seen therein the puncturing headpiece 122 has been reduced in overall size and shows a diminished diameter or girth in co",parison to its initial size as shown previously via Figs. 31-34 respectively. The reduced overall size and altered configuration of the puncturing headpieoe 122 Iying disposed within the arterial lumen in-vivo is a critical manipulation and step of the methodology.
After the puncturing headpiece has been reduced in overall size and has a diminished girth the overall diameter of the conll acled puncturing headpiece 122 is smaller in overall diameter and size than the dial"eter of the deformable cuff disposed directly behind the headpiece. Due to the reduced size of the puncturing head~iece 122 the deformable cuff and engaged vascular segment carried upon the elongated shaft 134 of the SUBSTITUTE SltEET (RULE 26) CA 022~7989 l998-l2-09 obturator may then be advanced farther through the puncture in the arterial wall 502 and be further advanced over the puncturing headl.iece 122 into the arterial lumen 504. This manipulation and result is illus~l~ted by Fig. 36.
It is i" ,po, lanl to recGyni~e and note that a s~ Ihsl~nlial portion of the 5 de~u,,,,a~12 cuff 300 has been extended over the outer shell 124 of the puncturing headpiece 122 in the ~anner illl~allaled by Fig. 36. Moreover cGnco",ilanl with the exlensiû,, of the defu~ able cuff 300 into the arterial lumen 504 the engaged and joined v~sc~ segment 400 is concurrently advanced and extended through the enlar~ed puncture or hole in the arterial 10 wall 502 at the chùsen site. The degree to which the end of the engaged v~scl ~- segment 400 is advanced lies at the cJiscriation of the surgeon pe, ror")ing this n ,ethûdology. If the surgeon so chooses the end of the e)r.cise~ V:~SC~)~?'Seyllle(ll joined to the def~ able cuff 300 may be e~.lel ,ded only through the arterial wall 502 but not markedly into the arterial lumen 504 15 itself. In the alle" ,alive the surgeon may choose to advance the end of the engaged v~Scl l~r sey,nent 400 further and thus position the open end of the v~scul- seg",ent 400 well within the intemal lumen of the artery itself. The deyl ee of entry and advancer"ent for the ~Jefor")able cuff and the enyaged v~scul~r segment thus is the choice and at the discretion of the surgeon at all 20 times.
After the defon"able cuff 300 and the engaged vAscll~-r seg-"ent 400 have been advanced such that each has penet,ated the arterial wall 502 and a portion of the clefor",a~le cuff 300 has been extended to cover in part the contracted puncturing headlJiece 122 to the surgeon s per~onal discrelion 25 and accor"r"oddtiûl, the surgeon will then activate the means for expanding the puncturing he~lri~ce 122. At the time of activating the ex~ ansion means for the puncturing headpiece 122 it is critical to recognize and appreciate that the uppermost region of the deror",dble cuff 300 enco",p~.cses and overlies the outer shell 124 and base plate 126 of the headpiece 122 -- as 30 shown by Fig. 36. It is not necess~ry that the defo,l"able cuff actually cover and envelope the pe, roralin~ end tip 130 although if the surgeon chooses to extend the defor",able cuff so far into the internal lumen of the artery the surgeon may do so at his discl ~tiûn. In each iu~a~ ~ce however when the means for e~ anding the puncturing headpiece 122 are inactivated the 35 overall size and girth of the puncturing headpiece will markedly increase. In the course of expanding in overall size and dimensions the puncturing SUBSTITUTE SHEET (RULE 26) CA 022~7989 1998-12-09 W O 97/47261 PCTrUS97/09503-- ~ta -headpiece will then make co~ cl with the upper position of the ¢3efor~"able cuff 300 which has been pre-positioned to envelope and er,co,l,pass the headpiece. Thus, as the overall size and girth of the puncturing headpiece 122 increases with time, the outer shell 124 of the headpiece will engage the 5 upper po,lion of the overlying defo"na~l~ cuff 300; and cons~4~ently apply expansion force to the sides of the de~r",~l.le cuff in-situ.
As the controlled ex~ sion force applied by the increasing girth of the puncturing headpiece 122 increases, the sidewall 306 of the cuff will clerol,ll,be bent outwardly, and become flaired and flattened out within the internal 10 lumen 504 of the artery ~00. Then, as the puncturing headpiece 122 expands in overall size and girth in ever greater degree, the defolllled sidewall of the cuff 300 will become more flallened; and will come to lie against the interior surface of the arterial wall 502; and thereby become secured to the arterial wall in a per"lanelll manner. This manipulation and 15 result is illustrated by Fig. 37.
As shown within Fig. 37, the puncturing headpiece 122 has been greatly enlarged and expanded as the headpiece lies within the arterial lumen 504. The controlled ex~ansion of the puncturing headpiece with the concomitant deformation and flairing of the uppermost portion of the cuff 300 20 occurs within the blood flow channel of the artery and is intended to be pe, rorlned without s~l~,st~nlially di"~i"ishing the rate of blood through the lumen of the artery or causing the heart of the patient to stop at any time.
The intentional and controlled dero, m~lion of the cuff 300 along its upper region as it lies disposed within the arterial lumen ~04 causes a perln~ne"l 25 flairing of the open meshwork of wires 308 for~,ing the sidewall 306. The de~(",ed sidewall is bent, maneuvered, and flaired solely by the expansion force of the puncturing headpiece. No other tool, article, or device is needed or utilized in order to cause a controlled expansion force and to create the deformation of the cuff while disposed within the central blood channel of the 30 artery in-vivo.
After the cufF has been controlably dercJIr~led within the arterial lumen 504 and become secured to the interior surface of the arterial wall 502 to the personal satisfa~Aion of the surgeon, the means for COI Itl a~til 19 the puncturing headpiece 122 are then once again activated. This col,lraclion of the 35 puncturing headpiece 122 serves to di,ninisl, the overall size and configuration of the headpiece and markedly reduces the girth of the outer SUBSTITUTE SH~I~T (RULE 26~

PCT~US97/09503-_y/_ shell 124 such that the overall ~ian~eter or girth of the puncturing headpiece beco"~es approxin)alely equal to or less than the diameter of the ~lo"yal~d shaft 134. The degree of collt,action for the puncturing headl-iece 122 is desirably cl~osen and correlated to the dia~n~ter of the enya~ed v~scl ~t~
5 seylllellt 400 then car,ie~ on the elo"yate~J shaft 134. By c~n~o"";"~ the overall size and girth of the puncturing l~e~d~iece to a size ap~,rox,",ately equal to the dia"~eter of the elG"galed shaft 134 the surgeon is confident that the overall di~",~ter of the ,ur~ ,ly corlt,acted puncturing hea~iece is now smaller than the internal lumen of the ~ngage-l vascular seg",enl and 10 U,ererore the conlra~ puncturing hea~piece will then be able to enter and pass con,~ tely through the internal lumen of the engaged v~-scul~r segment without meaningfully injuring or altering the inte" ~al surface of the blood flow ch~l ",el itself. The act of reducing the overall size and girth of the puncturing headpiece with the resulting CGI ,sequence that it may pass through and exit 15 the artery 500 is illusl,dted by Fig. 38.
After the puncturing headpiece has been co, nl acled to a minimal overall size and girth the entirety of the obturator 120 is withdrawn by the surgeon holding the ~roxin,al end of the obturator. The reduced size of the puncturing headpiece 122 shown previously by Fig. 38 will pass through the 20 interior of the deformed cuff 300 which is now secured in part within the internal lumen of the artery; and also pass through the inle" ,al lumen of the engaged v~scul~r sey",enl 400 which has been previously joined to the cuff in per",dnent fashion. The act of removing the obturator is quickly acco""~lished by the skilled surgeon; and the act of removal serves to isolate 2~ the now defor."ed sidewall 306 of the cuff 300 secured to the inte(ior surface of the arterial wall 502. The de~"ned cuff 300 and the enya~led vascular seyn,enl 400 and remain permanently secured and alldol)ed to the blood flow channel of the major artery in a ,nanner which permits a, lerial blood to enter through the deformed cuff into the internal lumen of the vascular segment without meaningful major aller~lion of the primary artery and without major destruction of v~sa~l- tissues at the site of graft bypass juncture. To ensure that the placement of the de~rllled cuff and engaged vascular segment is fluid-tight the surgeon then pr~rerably applies a biocolnpalible adhesive 530 to the exterior surface of the arterial wall 502 at the puncture site. The 35 bi3cor"patible adhesive 530 is desirably spread over the sidewall 306 of the cuff 300 at the exterior surface of the puncture site as is shown by Fig. 39.
SUBSTITUTE SltEET (RULE 26) PCT~US97tO9503-~ S~o2 ~
The bioco",pdlible adhesive dries quickly; forms a permanent and fluid-tight seal; and will not degrade or cause irritation to either the artery or the grafted vascular segment now to be used as a shunt. Note also that the catheter tube has desirably also been removed prior to the placement of the 5 bioco~lpdlible adl ~esive at the juncture site on the arterial wall. This caU~eter removal step is prere"~d in order to have better ~ccess to the derc,r",ed cuff at the v~scl~l~r site and the point of iuncture.
A number of difrerent biocGr"palible adhesives may be employed to seal pen"anenlly the puncture site in the manner shown by Fig. 39. A
10 representative but non-exhaustive listing of such biocompatible adhesives is provided by Table 4 below.

SUBSTITUTE SHEET (RULE 26) PCTAUS97tO9503-Table 4: Bioc~",patible Adhesives Adhesives fibrin glue;
histacryl (butyl-2-cyanoacrylate) tissue adl ,esive;
cyal ,oacl ylates;
liquid silicones;
epoxy resins; and polyurethal le adhesives.

SUBSTITUTE SHEET (RULE 26) -CA 022~7989 1998-12-09 W O97/47261 PCT~US97109503-The overall result of this procedure is illustrated by Fig. 40 in which the uppermost region of the cuff sidewall 306 has been deformed and flaired outwardly into the internal lumen ~04 of the artery 500. The open meshwork of wires 308 has aided and assisted the ease and speed by which the deformed sidewall has been bent and extended into the internal arterial lumen and become secured to the interior surface of the arterial wall 502.
Also, the placement of the biocompatible adhesive 503 at the puncture site and graft juncture places the byPass conduit in a fluid-ti~ht setting permanently such that the engaged vascular se~ment 400 has become attached to and is in blood flow communication with the arterial blood in an unobstructed manner. The placement and securing of the vascular ~raft to the major unobstructed artery is thus complete in all respects.
The other end of the excised vascular se~ment 400 is then conventionally attached to the obstructed blood vessel at a site distal to the obstruction itself. The manner of joining the other open end of the grafted vascular segment to the obstructed artery or vein may be achieved conventionally by anastomosis, with or without sutures and with or without use of tissue adhesives by the surgeon. It will be noted and appreciated also, that the sur~eon may in fact intentionally create an aperture in the wall of the grafted vascular se~ment 400, introduce the obturator 120 into the internal lumen of the vascular segment; place a second deformable cuff 300 in proper position; and then engage the cuff to the second open end of the vascular segment in the manner described previously. If the surgeon so chooses, therefore, the entirety of the introducer system and the catertization methodology may be repeated at the chosen site on the obstructed blood vessel. Nevertheless, it is generally expected that in most instances, the surgeon will prefer to perform conventional anastomosis as the means for ioining the other open end of the blood vessel segment to the obstructed artery or vein. This is illustrated by Fig. 41.
The entire catheterization methodology for creating a vascular bypass graft or shunt has been shown and described in detail via Figs. 33-41 inclusive. Each essential manipulation or required act has been illustrated in detail and described in depth. Nevertheless, to assure a complete and comprehensive presentation of the methodology as a whole, a summary recitation of the preferred surgical procedures using the catheter apparatus, the introducer system, and the methodology is provided hereinafter.

SUBSTITUTE S!~EET (RULE 26) CA 022~7989 1998-12-09 W O97/47261 PCTrUS97/09503--~5-Vl. SUMMARY OF THE PREFERRED SURGICAL PROCEDURES USING
THE CATHETER APPARATUS AND METHOD.
The catheter apparatus and methodology comprising the present 5 invention provides an approach designed to allow surgeons do multiple bypass using vein bypass grafts in a minimally invasive way. This procedure allows a simpler way to place the vein grafts proximally to the aorta and distally to the coronary artery without using a heart-lung machine and without need for stopping the heart. Small incisions are first made between the ribs;
10 a video camera and instruments with long handles are inserted; and, under the direct visualization, the aorta is punctured to create a proximal graft to anastomosis (aortotomy) using a specially prepared catheter introducer system which internally carries a deformable cuff and a previously excised V~SC~ r segment.
The deformable cuff is made of nitinol wire mesh (or other metals such as stainless steel or polymers); and is preferably coated with prosthetic material such as PTFE. The cuff will become anchored by deformation inside the aortic wall and be secured and blood-leak-proven outside the aortic wall by subsequently applying a tissue adhesive. This deformed cuff will provide 20 a secure sutureless aortic anastomosis for the bypass vein graft. The proximal part of the vein graft is preferably sewn to the cuff. The bypass graftis then distally anaslol"osed to the coronary artery, which can be done either by the conventional way with sutures or by applying tissue adhesive between the ~fljacent outer walls of the byp~ss~hle coronary artery and the bypass 25 vein graft without sutures.
This unique procedure simplifies the complexity of the conventional coronary artery bypass surgery and makes the surgery less invasive.
Moreover, this technique provides a critical advantage over the convenlional bypass surgery (using excised vein grafts), or the thoracoscopic minimally 30 invasive surgery (using an internal mammary vein graft). Also, it will shorten the operation time and make the coronary bypass surgery safer and more cost-effective.

SUBSTITUTE Sl IEET (RULE 26) CA 022~7989 1998-12-09 W O97/47261 PCTrUS97/09503--~6-Thoracotomy and Aorotocoronary Bypass:
After cutting through the muscle and other tissue of the anterior chest, the surgeon separates a rib from the breast bone and cuts a piece of the cartilage at the detached end to provide working space for the aortotomy and 5 placement of the proximal graft anastomosis.
The bypassing of the v~scul~r blockage increases blood flow to the heart. The optimal environment for the vascular anastomosis is a motionless, dry field. In conventional coronary bypass surgery, this environment can be obtained by total cardiopulmonary bypass and cardioplegia techniques to 10 arrest the heart. However, in minimally invasive coronary bypass surgery, it is performed without cardiopulmonary bypass and without stopping the heart.
Instead, the heart beat is slowed down with cardiac medications such as calcium channel blockers, beta-blockers and hypothermia.

15 Creation of the proximal anastomosis The ascending aorta is first palpated before creation of the aortotomy to determine the proper location of the aorta for aortotomy and delivery of the introducer system. The ascending aorta is preoperatively evaluated by means of CT scan or MRI to exclude the patient with severe atherosclerosis 20 of the aorta, which may interfere with creation of the aorotomy and increase possible associated complications such as dissection and embolization of the plaques. When the ascending aorta is shown to be moderately thick by CT
or MRI, the deformable cuff is larger (7 to 8 mm outer diameter~ than usual (5 to 6 mm outer diameter) and may be placed in the aorta to prevent narrowing 25 at the proximal anastomosis.
This technique involves safe and simple placement of the proximal anastomosis of the vein graft without clamping of the aorta and without using heart-lung machine. The proximal part of the ascending thoracic aorta is first exposed and punctured with an obturator that carries a cuff and a previously 30 excised blood vessel segment within it (Figs. 32-34). The cuff is made of a nitinol wire mesh (or other metals such as stainless steel or polymers) and has a flared end, which will firmly anchor its deformed and flared proximal end against the inner wall of the thoracic aorta. The cufl is desirably covered with a prosthetic material (such as Dacron and PTFE, etc.) to prevent any 35 leaking of blood through the mesh cuff. Continuous 5-0 Prolene is used for SUBSTITUTE SHEET (RULE 26) CA 022~7989 1998-12-09 --~7--the anastomosis between the cuff and the grafts when the saphenous vein is the usual size (5 to 6 mm).
After the aortic puncture, the proximal end of the cuff vein graft is deformed and released into the arterial lumen as the obturator is being 5 retracted (Figs. 35-39). The vein graft is slowly pulled back until the cuff is anchored against the internal wall of the aorta via its deformed flared end.
Once the cuff and the proximal end of the vein graft is internally anchored, then tissue adhesive (glue) is applied around the exit site of the graft (between the graft and the adjacent outer wall of the aorta) so that any 10 possibility of leakage of blood will be minimized and also to secure further the proximal anastomosis. The upper end of the vein graft is clamped to stop blood flow; and drugs are injected into the lower end to prevent it from going into spasm while the surgeon works on the coronary anastomosis.

15 Exposure of the coronarY arteries and creation of the distal anastomosis The sac covering the heart is cut, the thin coronary artery is under direct view. The patient is given calcium channel blockers and a beta blocker intravenously to slow the heart, which facilitate that the surgeons thread the stitches through the artery. The coronary artery vessels to be bypassed is 20 identified and exposed after opening either hemithorax.
With a sharp knife, the surgeons cut into the coronary artery (arteriotomy). The arteriotomy is then increased to 8 to 12 mm with Pott's or reversed acute angle scissors. The internal diameter of the coronary artery is calibrated and the size recorded. The distal part of the graft that has been 25 set aside is sewn to the coronary artery with the same fine sutures that are used in standard bypass operations (Fig. 41). A continuous suture of 6-0 or 7-0 Prolene is begun in the heel of the vein graft with a narrow mattress stitchand continued to the proximal portion of the coronary artery. Approximately 1-mm bites are taken as the suture line is continued around one side to the 30 distal end. At that point the suture line may be interrupted with one or moresutures. With smaller vessels interrupted sutures are easy to insert and less likely to constrict the anaslolnosis. With larger vessels (2.5 mm or greater) the suture line may be continued without interruption around the distal end.
The other end of the original stitch is continued on the contralateral side, and35 the anastomosis is terminated at the midpoint of the arteriotomy.
Anastomotic patency is checked in both directions. A flush of clear solution SUBSTITUTE S~IEET (RULE 26) . .

CA 022~7989 l998-l2-09 -~8-through the needle may be of aid during the performance of the distal anastomosis to keep the anastomotic area free of blood. Alternatively, the coronary artery and bypass vein grafts can be anastomosed by applying tissue adhesive (glue) between their adjacent outer walls, without using 5 sutures, which facilitates and expedites the coronary anastomosis. when application of tissue adhesive make two structures bonded in a side-to-side fashion, a fenestration in a proper length is made between them by putting an incision extending from the lumen of vein graft to the lumen of the coronary artery with a knife inserted via the distal open end of the graft. After this, the 10 open distal end of the vein graft is sewn as a blind end.
This procedure is repeated until all the blocked vessels to be revascularized are bypassed. After checking for bleeding, the surgeon closes the chest.
The present invention is not to be limited in scope nor restricted in 15 form except by the claims appended hereto.

SUBSTITUTE SHEE~ (RULE 2

Claims (12)

. 49 What I claim is:
1. A catheter apparatus for creating a vascular bypass on-demand between an unobstructed blood vessel and an obstructed blood vessel in-vivo using a previously excised vascular segment as a conduit, said vascular bypass catheter apparatus comprising:
a catheter suitable for introduction into and extension through the body in-vivo, said catheter being comprised of (a) a hollow tube of fixed axial length having a discrete proximal end, a discrete distal end, and at least one internal lumen of predetermined diameter, and (b) a distal end tip adapted for guidance of said catheter in-vivo to a chose site wherein an unobstructed blood vessel is in anatomic proximity to an obstruction lying within another blood vessel;
an obturator for on-demand introduction and passage through said catheter to a chosen site on the unobstructed blood vessel in-vivo, said obturator comprising (1) an expandable and contractible puncturing headpiece for puncture of and entry into the lumen of an unobstructed blood vessel, said puncturing headpiece being expandable on-demand to a size greater than the diameter of said internal lumen of said catheter and being contractible on-demand to a size less than the diameter of said internal lumen of said catheter, (2) a perforating end tip on said puncturing headpiece to facilitate the perforation of a biood vessel wall at the chosen vascular site in-vivo (3) an elongated shaft of fixed axial length integrated with said puncturing headpiece, said elongated shaft being configured for the carrying and transport of the previously excised vascular segment with said internal lumen of said catheter to the chosen site on the unobstructed blood vessel in-vivo, (4) means for expanding and contracting said puncturing headpiece of said obturator on-demand; and a deformable cuff for positioning over said elongated shaft adjacent to said puncturing headpiece of said obturator together with a previously excised vascular segment (i) wherein, prior to the perforation of the unobstructed blood vessel in-vivo by said puncturing headpiece of said obturator, at least a portion of said deformable cuff has been engaged and joined to one end of the excised vascular segment then carried by said elongated shaft of said obturator, (ii) and wherein, after the perforation of the unobstructed blood vessel in-vivo by said puncturing headpiece of said obturator, at least part of said engaged cuff is extended into the lumen of the unobstructed blood vessel, is partially deformed in-situ by an expansion of said puncturing headpiece of said obturator, and said engaged cuff becomes attached via said partial deformation to the interior of the unobstructed blood vessel, (iii) and whereby said cuff engaged end of the previously excised vascular segment become secured to and placed in blood flow communication with the unobstructed blood vessel and serves as vascular conduit means for bypassing an obstruction and restoring blood flow from the unobstructed blood vessel to the obstructed blood vessel.
2. The catheter apparatus as recited in claim 1 wherein said deformable cuff is comprised of metal.
3. The catheter apparatus as recited in claim 1 wherein said deformable cuff is comprised of a polymeric material.
4. The catheter apparatus as recited in claim 1 wherein said deformable cuff is overlaid with prosthetic matter.
5. The catheter apparatus as recited in claim 1 wherein said deformable cuff comprises an open meshwork.
6. The catheter apparatus as recited in claim 1 wherein said deformable cuff comprises a solid mass of material.
7. The catheter apparatus as recited in claim 1 wherein said means for expanding and contracting said puncturing headpiece further comprises a mechanical assembly.
8. The catheter apparatus as recited in claim 1 wherein said means for expanding and contracting said puncturing headpiece further comprises a hydraulic assembly.
9 A catheterization method for creating a vascular bypass on-demand between an unobstructed blood vessel and an obstructed blood vessel in-vivo using a previously excised vascular segment as a conduit, said vascular bypass catheterization method comprising the steps of:
providing a catheter suitable for introduction into and extension through the body in-vivo, said catheter being comprised of (a) a hollow tube of fixed axial length having a discrete proximal end, a discrete distal end, and at least one internal lumen of predetermined diameter, and (b) a distal end tip adapted for guidance of said catheter in-vivo to a chosen site wherein an unobstructed blood vessel is in anatomic proximity to an obstruction lying within another blood vessel;
providing an obturator for on-demand introduction and passage through said catheter to a chosen site on the unobstructed blood vessel in-vivo, said obturator comprising (1) an expandable and contractible puncturing headpiece for puncture of and entry into the lumen of an unobstructed blood vessel, said puncturing headpiece being expandable on-demand to a size greater than the diameter of said internal lumen of said catheter and also being contractible on-demand to a size less than the diameter of said internal lumen of said catheter, (2) a perforating end tip of said puncturing headpiece to facilitate the perforation of a blood vessel wall at the chosen site in-vivo (3) an elongated shaft of fixed axial length integrated with said puncturing headpiece, said elongated shaft being configured for the carrying and transport of a previously excised vascular segment with said internal lumen of said catheter to the chosen vascular site on the unobstructed blood vessel, (4) means for expanding and contracting said puncturing headpiece of said obturator on-demand;
placing a previously excised vascular segment on the elongated shaft adjacent to said puncturing headpiece of said obturator;

positioning a deformable cuff over said elongated shaft and one end of the previously excised vascular segment lying adjacent to said puncturing headpiece of said obturator such that at least a portion of said deformable cuff engages and is joined to the end of the excised vascular segment;
perforating the unobstructed blood vessel at the chosen site in-vivo using said puncturing headpiece of said obturator;
extending at least part of said engaged cuff into the lumen of the unobstructed blood vessel;
partially deforming said extended cuff in-situ by an expansion of said puncturing headpiece of said obturator (i) whereby said engaged cuff becomes attached via said partial deformation to the interior of the unobstructed blood vessel, (ii) and whereby said cuff engaged end of the previously excised vascular segment become secured to and placed in blood flow communication with the unobstructed blood vessel; and joining the other end of the secured vascular segment to the obstructed blood vessel at a chosen site distal to the obstruction, said joined segment serving as vascular conduit for means for bypassing the obstruction and restoring blood flow from the unobstructed blood vessel to the obstructed blood vessel.
10. The catheterization method as recited in claim 9 wherein the vascular bypass is created between an unobstructed artery and an obstructed artery.
11. The catheterization method as recited in claim 9 wherein the vascular bypass is created between an unobstructed vein and an obstructed vein.
12. The catheterization method as recited in claim 9 wherein said vascular bypass is created between an artery and a vein.
CA002257989A 1996-06-14 1997-06-04 Catheter apparatus and method for creating a vascular bypass in vivo Abandoned CA2257989A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/664,165 US5676670A (en) 1996-06-14 1996-06-14 Catheter apparatus and method for creating a vascular bypass in-vivo
US08/664,165 1996-06-14

Publications (1)

Publication Number Publication Date
CA2257989A1 true CA2257989A1 (en) 1997-12-18

Family

ID=24664845

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002257989A Abandoned CA2257989A1 (en) 1996-06-14 1997-06-04 Catheter apparatus and method for creating a vascular bypass in vivo

Country Status (6)

Country Link
US (1) US5676670A (en)
EP (1) EP0910320A4 (en)
JP (1) JP3322404B2 (en)
AU (1) AU729340B2 (en)
CA (1) CA2257989A1 (en)
WO (1) WO1997047261A1 (en)

Families Citing this family (266)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69638011D1 (en) 1995-10-13 2009-10-08 Medtronic Vascular Inc NGRIFF
CA2244066A1 (en) 1996-02-02 1997-08-07 Transvascular, Inc. A device, system and method for interstitial transvascular intervention
IL125416A0 (en) 1996-02-02 1999-03-12 Transvascular Inc Methods and apparatus for connecting openings formed in adjacent blood vessels or other anatomical structures
US6007544A (en) * 1996-06-14 1999-12-28 Beth Israel Deaconess Medical Center Catheter apparatus having an improved shape-memory alloy cuff and inflatable on-demand balloon for creating a bypass graft in-vivo
US5797920A (en) * 1996-06-14 1998-08-25 Beth Israel Deaconess Medical Center Catheter apparatus and method using a shape-memory alloy cuff for creating a bypass graft in-vivo
US6482224B1 (en) * 1996-08-22 2002-11-19 The Trustees Of Columbia University In The City Of New York Endovascular flexible stapling device
US6293955B1 (en) 1996-09-20 2001-09-25 Converge Medical, Inc. Percutaneous bypass graft and securing system
US6432127B1 (en) 1996-10-11 2002-08-13 Transvascular, Inc. Devices for forming and/or maintaining connections between adjacent anatomical conduits
US6120432A (en) 1997-04-23 2000-09-19 Vascular Science Inc. Medical grafting methods and apparatus
US5941908A (en) * 1997-04-23 1999-08-24 Vascular Science, Inc. Artificial medical graft with a releasable retainer
US5972017A (en) 1997-04-23 1999-10-26 Vascular Science Inc. Method of installing tubular medical graft connectors
US6036702A (en) * 1997-04-23 2000-03-14 Vascular Science Inc. Medical grafting connectors and fasteners
US5976178A (en) * 1996-11-07 1999-11-02 Vascular Science Inc. Medical grafting methods
AU721415B2 (en) * 1996-11-08 2000-07-06 Converge Medical, Inc. Percutaneous bypass graft and securing system
US6026814A (en) * 1997-03-06 2000-02-22 Scimed Life Systems, Inc. System and method for percutaneous coronary artery bypass
US6155264A (en) * 1997-03-06 2000-12-05 Scimed Life Systems, Inc. Percutaneous bypass by tunneling through vessel wall
US6035856A (en) 1997-03-06 2000-03-14 Scimed Life Systems Percutaneous bypass with branching vessel
US6136007A (en) * 1997-04-17 2000-10-24 St. Jude Medical Cardiovascular Group, Inc, Apparatus for handling tubing used in medical procedures
US20020087046A1 (en) * 1997-04-23 2002-07-04 St. Jude Medical Cardiovascular Group, Inc. Medical grafting methods and apparatus
US5944730A (en) * 1997-05-19 1999-08-31 Cardio Medical Solutions, Inc. Device and method for assisting end-to-side anastomosis
US6409739B1 (en) 1997-05-19 2002-06-25 Cardio Medical Solutions, Inc. Device and method for assisting end-to side anastomosis
US6730103B2 (en) 1997-05-19 2004-05-04 Pepi Dakov Connector system and methods for cutting and joining hollow anatomical structures
US6056762A (en) 1997-05-22 2000-05-02 Kensey Nash Corporation Anastomosis system and method of use
US6443158B1 (en) 1997-06-19 2002-09-03 Scimed Life Systems, Inc. Percutaneous coronary artery bypass through a venous vessel
US6092526A (en) 1997-06-19 2000-07-25 Scimed Life Systems, Inc. Percutaneous chamber-to-artery bypass
US6213126B1 (en) 1997-06-19 2001-04-10 Scimed Life Systems, Inc. Percutaneous artery to artery bypass using heart tissue as a portion of a bypass conduit
US5922022A (en) * 1997-09-04 1999-07-13 Kensey Nash Corporation Bifurcated connector system for coronary bypass grafts and methods of use
US6063114A (en) * 1997-09-04 2000-05-16 Kensey Nash Corporation Connector system for vessels, ducts, lumens or hollow organs and methods of use
US6017352A (en) * 1997-09-04 2000-01-25 Kensey Nash Corporation Systems for intravascular procedures and methods of use
US6074416A (en) 1997-10-09 2000-06-13 St. Jude Medical Cardiovascular Group, Inc. Wire connector structures for tubular grafts
NL1007349C2 (en) 1997-10-24 1999-04-27 Suyker Wilhelmus Joseph Leonardus System for the mechanical production of anastomoses between hollow structures; as well as device and applicator for use therewith.
US6330884B1 (en) * 1997-11-14 2001-12-18 Transvascular, Inc. Deformable scaffolding multicellular stent
US6193734B1 (en) 1998-01-23 2001-02-27 Heartport, Inc. System for performing vascular anastomoses
US6416527B1 (en) * 1998-01-28 2002-07-09 St. Jude Medical Cardiovascular Group, Inc. Vessel cutting device
AU1923999A (en) 1998-01-30 1999-08-16 Vascular Science Inc. Medical graft connector or plug structures, and methods of making and installingsame
US6994713B2 (en) * 1998-01-30 2006-02-07 St. Jude Medical Atg, Inc. Medical graft connector or plug structures, and methods of making and installing same
US6352543B1 (en) 2000-04-29 2002-03-05 Ventrica, Inc. Methods for forming anastomoses using magnetic force
US20020144696A1 (en) 1998-02-13 2002-10-10 A. Adam Sharkawy Conduits for use in placing a target vessel in fluid communication with a source of blood
US6651670B2 (en) 1998-02-13 2003-11-25 Ventrica, Inc. Delivering a conduit into a heart wall to place a coronary vessel in communication with a heart chamber and removing tissue from the vessel or heart wall to facilitate such communication
NO981277D0 (en) 1998-03-20 1998-03-20 Erik Fosse Method and apparatus for suture-free anastomosis
EP1077662A1 (en) 1998-04-16 2001-02-28 Beth Israel Deaconess Medical Center Catheter apparatus having an improved shape-memory alloy cuff and inflatable on-demand balloon for creating a bypass graft in vivo
US6726704B1 (en) 1998-05-29 2004-04-27 By-Pass, Inc. Advanced closure device
US7022131B1 (en) 1998-05-29 2006-04-04 By-Pass Inc. Methods and devices for vascular surgery
US7063711B1 (en) 1998-05-29 2006-06-20 By-Pass, Inc. Vascular surgery
US6979338B1 (en) 1998-05-29 2005-12-27 By-Pass Inc. Low profile anastomosis connector
US6641593B1 (en) 1998-06-03 2003-11-04 Coalescent Surgical, Inc. Tissue connector apparatus and methods
US6613059B2 (en) 1999-03-01 2003-09-02 Coalescent Surgical, Inc. Tissue connector apparatus and methods
US6945980B2 (en) 1998-06-03 2005-09-20 Medtronic, Inc. Multiple loop tissue connector apparatus and methods
AU761192B2 (en) 1998-06-10 2003-05-29 Converge Medical, Inc. Sutureless anastomosis systems
US6080175A (en) * 1998-07-29 2000-06-27 Corvascular, Inc. Surgical cutting instrument and method of use
US6461320B1 (en) 1998-08-12 2002-10-08 Cardica, Inc. Method and system for attaching a graft to a blood vessel
US6206913B1 (en) 1998-08-12 2001-03-27 Vascular Innovations, Inc. Method and system for attaching a graft to a blood vessel
US6325813B1 (en) 1998-08-18 2001-12-04 Scimed Life Systems, Inc. Method and apparatus for stabilizing vascular wall
US6196230B1 (en) 1998-09-10 2001-03-06 Percardia, Inc. Stent delivery system and method of use
US6290728B1 (en) * 1998-09-10 2001-09-18 Percardia, Inc. Designs for left ventricular conduit
EP1112043B1 (en) 1998-09-10 2006-04-05 Percardia, Inc. Tmr shunt
WO2000015147A1 (en) 1998-09-10 2000-03-23 Percardia, Inc. Transmycardial shunt and its attachment mechanism, for left ventricular revascularization
US6261304B1 (en) 1998-09-10 2001-07-17 Percardia, Inc. Delivery methods for left ventricular conduit
US6152937A (en) * 1998-11-06 2000-11-28 St. Jude Medical Cardiovascular Group, Inc. Medical graft connector and methods of making and installing same
US6508252B1 (en) 1998-11-06 2003-01-21 St. Jude Medical Atg, Inc. Medical grafting methods and apparatus
US6475222B1 (en) 1998-11-06 2002-11-05 St. Jude Medical Atg, Inc. Minimally invasive revascularization apparatus and methods
US6113612A (en) * 1998-11-06 2000-09-05 St. Jude Medical Cardiovascular Group, Inc. Medical anastomosis apparatus
US7578828B2 (en) 1999-01-15 2009-08-25 Medtronic, Inc. Methods and devices for placing a conduit in fluid communication with a target vessel
US8118822B2 (en) 1999-03-01 2012-02-21 Medtronic, Inc. Bridge clip tissue connector apparatus and methods
EP1161185A2 (en) * 1999-03-09 2001-12-12 St. Jude Medical Cardiovascular Group, Inc. Medical grafting methods and apparatus
US6695859B1 (en) 1999-04-05 2004-02-24 Coalescent Surgical, Inc. Apparatus and methods for anastomosis
US6537299B1 (en) 1999-04-05 2003-03-25 Ethicon, Inc. Intravascular hemostasis device and method
US6743244B2 (en) 1999-04-16 2004-06-01 Integrated Vascular Interventional Technologies, L.C. Soft anvil apparatus for cutting anastomosis fenestra
US6626921B2 (en) 1999-04-16 2003-09-30 Integrated Vascular Interventional Technologies, L.C. Externally positioned anvil apparatus for cutting anastomosis
US6726694B2 (en) 1999-04-16 2004-04-27 Integrated Vascular Interventional Technologies, L.C. (Ivit, Lc) Intraluminally directed anvil apparatus and related methods and systems
US7981126B2 (en) 1999-04-16 2011-07-19 Vital Access Corporation Locking compression plate anastomosis apparatus
US6623494B1 (en) 1999-04-16 2003-09-23 Integrated Vascular Interventional Technologies, L.C. (Ivit, Lc) Methods and systems for intraluminally directed vascular anastomosis
US6712836B1 (en) 1999-05-13 2004-03-30 St. Jude Medical Atg, Inc. Apparatus and methods for closing septal defects and occluding blood flow
US6428550B1 (en) 1999-05-18 2002-08-06 Cardica, Inc. Sutureless closure and deployment system for connecting blood vessels
US6673088B1 (en) 1999-05-18 2004-01-06 Cardica, Inc. Tissue punch
AU5143000A (en) 1999-05-18 2000-12-05 Vascular Innovations, Inc. Implantable medical device such as an anastomosis device
US20050119599A1 (en) * 1999-05-18 2005-06-02 A-Med Systems, Inc. Supplemental port for catheter perfusion of surgical site and methods of use
US6719769B2 (en) 1999-11-15 2004-04-13 Cardica, Inc. Integrated anastomosis tool with graft vessel attachment device and cutting device
US6699256B1 (en) 1999-06-04 2004-03-02 St. Jude Medical Atg, Inc. Medical grafting apparatus and methods
US6179849B1 (en) 1999-06-10 2001-01-30 Vascular Innovations, Inc. Sutureless closure for connecting a bypass graft to a target vessel
US9814869B1 (en) 1999-06-15 2017-11-14 C.R. Bard, Inc. Graft-catheter vascular access system
US7416554B2 (en) 2002-12-11 2008-08-26 Usgi Medical Inc Apparatus and methods for forming and securing gastrointestinal tissue folds
US7744613B2 (en) 1999-06-25 2010-06-29 Usgi Medical, Inc. Apparatus and methods for forming and securing gastrointestinal tissue folds
AU6059200A (en) 1999-07-02 2001-01-22 Quickpass, Inc. Suturing device
US7850703B2 (en) 1999-07-28 2010-12-14 Cardica, Inc. System for performing anastomosis
US6391038B2 (en) 1999-07-28 2002-05-21 Cardica, Inc. Anastomosis system and method for controlling a tissue site
US7014644B1 (en) 1999-07-28 2006-03-21 Cardica, Inc. Tissue bonding system and method for controlling a tissue site during anastomosis
US7682368B1 (en) 1999-07-28 2010-03-23 Cardica, Inc. Anastomosis tool actuated with stored energy
US7766924B1 (en) 1999-07-28 2010-08-03 Cardica, Inc. System for performing anastomosis
US20050154406A1 (en) * 1999-07-28 2005-07-14 Cardica, Inc. Method for anastomosing vessels
US7285131B1 (en) 1999-07-28 2007-10-23 Cardica, Inc. System for performing anastomosis
US7300444B1 (en) 1999-07-28 2007-11-27 Cardica, Inc. Surgical system and method for connecting hollow tissue structures
US7892246B2 (en) 1999-07-28 2011-02-22 Bioconnect Systems, Inc. Devices and methods for interconnecting conduits and closing openings in tissue
US6253768B1 (en) 1999-08-04 2001-07-03 Percardia, Inc. Vascular graft bypass
US6302892B1 (en) 1999-08-04 2001-10-16 Percardia, Inc. Blood flow conduit delivery system and method of use
US6638237B1 (en) 1999-08-04 2003-10-28 Percardia, Inc. Left ventricular conduits and methods for delivery
US6702828B2 (en) * 1999-09-01 2004-03-09 Converge Medical, Inc. Anastomosis system
US6494889B1 (en) 1999-09-01 2002-12-17 Converge Medical, Inc. Additional sutureless anastomosis embodiments
US20020173809A1 (en) * 1999-09-01 2002-11-21 Fleischman Sidney D. Sutureless anastomosis system deployment concepts
US8529583B1 (en) 1999-09-03 2013-09-10 Medtronic, Inc. Surgical clip removal apparatus
US6605053B1 (en) 1999-09-10 2003-08-12 Percardia, Inc. Conduit designs and related methods for optimal flow control
US6926730B1 (en) 2000-10-10 2005-08-09 Medtronic, Inc. Minimally invasive valve repair procedure and apparatus
US6402764B1 (en) 1999-11-15 2002-06-11 Cardica, Inc. Everter and threadthrough system for attaching graft vessel to anastomosis device
US6602263B1 (en) * 1999-11-30 2003-08-05 St. Jude Medical Atg, Inc. Medical grafting methods and apparatus
US20040068278A1 (en) * 1999-12-06 2004-04-08 Converge Medical Inc. Anastomosis systems
US6669708B1 (en) * 1999-12-09 2003-12-30 Michael Nissenbaum Devices, systems and methods for creating sutureless on-demand vascular anastomoses and hollow organ communication channels
AU4523301A (en) * 1999-12-14 2001-06-25 Radiant Medical, Inc. Method for reducing myocardial infarct by applicaton of intravascular hypothermia
US6428555B1 (en) * 2000-01-28 2002-08-06 J. Kenneth Koster, Jr. Anastomosis punch device and method
US6551332B1 (en) 2000-03-31 2003-04-22 Coalescent Surgical, Inc. Multiple bias surgical fastener
US7232449B2 (en) * 2000-04-29 2007-06-19 Medtronic, Inc. Components, systems and methods for forming anastomoses using magnetism or other coupling means
US8518062B2 (en) 2000-04-29 2013-08-27 Medtronic, Inc. Devices and methods for forming magnetic anastomoses between vessels
US6854467B2 (en) 2000-05-04 2005-02-15 Percardia, Inc. Methods and devices for delivering a ventricular stent
US20040215233A1 (en) * 2000-06-16 2004-10-28 Magenta Medical Corporation Methods and apparatus for forming anastomotic sites
US6712831B1 (en) * 2000-06-16 2004-03-30 Aaron V. Kaplan Methods and apparatus for forming anastomotic sites
US6596003B1 (en) * 2000-06-28 2003-07-22 Genzyme Corporation Vascular anastomosis device
GB0019107D0 (en) * 2000-08-03 2000-09-27 Ranier Ltd Balloon-free uninary catheter
DE60124285T3 (en) 2000-09-29 2011-03-17 Cordis Corp., Miami Lakes COATED MEDICAL EQUIPMENT
US6776785B1 (en) 2000-10-12 2004-08-17 Cardica, Inc. Implantable superelastic anastomosis device
US6602286B1 (en) * 2000-10-26 2003-08-05 Ernst Peter Strecker Implantable valve system
US20050234483A1 (en) * 2000-11-06 2005-10-20 Cardica, Inc. Unitary anastomosis device
US6554764B1 (en) 2000-11-13 2003-04-29 Cardica, Inc. Graft vessel preparation device and methods for using the same
US6471713B1 (en) 2000-11-13 2002-10-29 Cardica, Inc. System for deploying an anastomosis device and method of performing anastomosis
US20040236170A1 (en) * 2000-11-15 2004-11-25 Ducksoo Kim Method for surgically joining a ventricular assist device to the cardiovascular system of a living subject using a piercing introducer assembly
US7909837B2 (en) 2000-12-13 2011-03-22 Medtronic, Inc. Methods, devices and systems for forming magnetic anastomoses
US20020095166A1 (en) 2001-01-16 2002-07-18 Jaime Vargas Incision tensioning system and method for using the same
DE10104361A1 (en) * 2001-02-01 2002-08-08 Fumedica Intertrade Ag Huenenb Combination of vascular prosthesis and holding element
US6620177B2 (en) 2001-02-15 2003-09-16 Novare Surgical Systems, Inc. Anastomosis occlusion device
US6953464B2 (en) 2001-02-21 2005-10-11 Novare Surgical Systems, Inc. Anastomosis occlusion device
WO2002091930A1 (en) * 2001-05-11 2002-11-21 Applied Medical Resources Corporation Traction trocar apparatus and method
EP1387638A2 (en) * 2001-05-14 2004-02-11 St. Jude Medical ATG, Inc. Medical grafting methods and apparatus
US20020183769A1 (en) * 2001-05-30 2002-12-05 St. Jude Medical Atg, Inc. Medical grafting methods and apparatus
US7338514B2 (en) 2001-06-01 2008-03-04 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods and tools, and related methods of use
CN100415180C (en) * 2001-06-20 2008-09-03 帕克医疗有限责任公司 Anastomotic device
US7115136B2 (en) 2001-06-20 2006-10-03 Park Medical Llc Anastomotic device
US6626920B2 (en) 2001-07-05 2003-09-30 Converge Medical, Inc. Distal anastomosis system
US20060064119A9 (en) * 2001-07-05 2006-03-23 Converge Medical, Inc. Vascular anastomosis systems
US20030229365A1 (en) * 2002-06-10 2003-12-11 Whayne James G. Angled vascular anastomosis system
US6972023B2 (en) * 2001-07-05 2005-12-06 Converge Medical, Inc. Distal anastomosis system
US6858035B2 (en) 2001-07-05 2005-02-22 Converge Medical, Inc. Distal anastomosis system
US6605098B2 (en) 2001-09-28 2003-08-12 Ethicon, Inc. Surgical device for creating an anastomosis between first and second hollow organs
US7108701B2 (en) * 2001-09-28 2006-09-19 Ethicon, Inc. Drug releasing anastomosis devices and methods for treating anastomotic sites
US7892247B2 (en) 2001-10-03 2011-02-22 Bioconnect Systems, Inc. Devices and methods for interconnecting vessels
US6814743B2 (en) 2001-12-26 2004-11-09 Origin Medsystems, Inc. Temporary seal and method for facilitating anastomosis
US8012164B1 (en) 2002-01-22 2011-09-06 Cardica, Inc. Method and apparatus for creating an opening in the wall of a tubular vessel
US7427261B1 (en) 2002-01-23 2008-09-23 Cardica, Inc. System for preparing a craft vessel for anastomosis
US6821286B1 (en) 2002-01-23 2004-11-23 Cardica, Inc. System for preparing a graft vessel for anastomosis
US20030144676A1 (en) * 2002-01-25 2003-07-31 Koster J. Kenneth Anastomosis device and method
US20050267498A1 (en) * 2002-04-30 2005-12-01 Cardica, Inc. Tissue everting device and method
US7976564B2 (en) 2002-05-06 2011-07-12 St. Jude Medical, Cardiology Division, Inc. PFO closure devices and related methods of use
US7351247B2 (en) * 2002-09-04 2008-04-01 Bioconnect Systems, Inc. Devices and methods for interconnecting body conduits
US8066724B2 (en) 2002-09-12 2011-11-29 Medtronic, Inc. Anastomosis apparatus and methods
US8105345B2 (en) 2002-10-04 2012-01-31 Medtronic, Inc. Anastomosis apparatus and methods
GB0223327D0 (en) * 2002-10-08 2002-11-13 Ranier Ltd Artificial spinal disc
US7942884B2 (en) 2002-12-11 2011-05-17 Usgi Medical, Inc. Methods for reduction of a gastric lumen
US7942898B2 (en) * 2002-12-11 2011-05-17 Usgi Medical, Inc. Delivery systems and methods for gastric reduction
US8377082B2 (en) * 2003-01-14 2013-02-19 Medtronic, Inc. Methods and apparatus for making precise incisions in body vessels
US20040236178A1 (en) * 2003-02-14 2004-11-25 Cardica, Inc. Method for preparing a graft vessel for anastomosis
US7077801B2 (en) 2003-02-19 2006-07-18 Corlife Gbr Methods and devices for improving cardiac output
US20040267306A1 (en) 2003-04-11 2004-12-30 Velocimed, L.L.C. Closure devices, related delivery methods, and related methods of use
US8372112B2 (en) 2003-04-11 2013-02-12 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods, and related methods of use
CA2426378C (en) * 2003-04-30 2012-03-13 Sawquip International Inc. Log positioning and conveying apparatus
US8114102B2 (en) * 2003-06-16 2012-02-14 St. Jude Medical Atg, Inc. Temporary hemostatic plug apparatus and method of use
US7794471B1 (en) 2003-06-26 2010-09-14 Cardica, Inc. Compliant anastomosis system
US8574246B1 (en) 2004-06-25 2013-11-05 Cardica, Inc. Compliant anastomosis system utilizing suture
US7182769B2 (en) 2003-07-25 2007-02-27 Medtronic, Inc. Sealing clip, delivery systems, and methods
US20050043749A1 (en) * 2003-08-22 2005-02-24 Coalescent Surgical, Inc. Eversion apparatus and methods
US8394114B2 (en) 2003-09-26 2013-03-12 Medtronic, Inc. Surgical connection apparatus and methods
US7452363B2 (en) * 2003-09-30 2008-11-18 Ethicon Endo-Surgery, Inc. Applier for fastener for single lumen access anastomosis
US20050070935A1 (en) * 2003-09-30 2005-03-31 Ortiz Mark S. Single lumen access deployable ring for intralumenal anastomosis
US7309341B2 (en) * 2003-09-30 2007-12-18 Ethicon Endo-Surgery, Inc. Single lumen anastomosis applier for self-deploying fastener
US8211142B2 (en) 2003-09-30 2012-07-03 Ortiz Mark S Method for hybrid gastro-jejunostomy
US20050262673A1 (en) * 2003-10-09 2005-12-01 Strahm Textile Systems Ag Device for removing needles from a fabric web
US20050101968A1 (en) * 2003-11-12 2005-05-12 Dadourian Daniel G. Ostial locator device and methods for transluminal interventions
US7879047B2 (en) 2003-12-10 2011-02-01 Medtronic, Inc. Surgical connection apparatus and methods
US8080023B2 (en) * 2003-12-12 2011-12-20 Vitalitec International, Inc. Device and method for performing multiple anastomoses
US7585306B2 (en) 2003-12-24 2009-09-08 Maquet Cardiovascular Llc Anastomosis device, tools and methods of using
US20070038283A1 (en) * 2004-02-06 2007-02-15 Mustapha Jihad A Ostial stent and balloon
US7500980B2 (en) * 2004-05-07 2009-03-10 Ethicon Endo-Surgery, Inc. Method and instrument for effecting anastomosis of respective tissues defining two body lumens
US8162963B2 (en) 2004-06-17 2012-04-24 Maquet Cardiovascular Llc Angled anastomosis device, tools and method of using
US8202248B2 (en) 2004-08-18 2012-06-19 Sequana Medical Ag Dialysis implant and methods of use
US7515970B2 (en) 2004-08-18 2009-04-07 Cardiac Pacemakers, Inc. Transeptal lead
GB0419954D0 (en) 2004-09-08 2004-10-13 Advotek Medical Devices Ltd System for directing therapy
US7789890B2 (en) * 2005-03-30 2010-09-07 Ethicon Endo-Surgery, Inc. Harness and balloon catheter assembly and method for use in anastomosis procedures
US20070021819A1 (en) * 2005-05-23 2007-01-25 Jeff Krolik Apparatus and Methods for Locating an Ostium of a Vessel
EP1909655A2 (en) 2005-06-20 2008-04-16 Sutura, Inc. Method and apparatus for applying a knot to a suture
US7951182B2 (en) 2005-07-14 2011-05-31 Zoll Circulation, Inc. System and method for leak detection in external cooling pad
WO2007038774A2 (en) * 2005-09-30 2007-04-05 Incept, Llc Apparatus for locating an ostium of a vessel
CA2627400A1 (en) * 2005-10-28 2007-05-03 Incept, Llc Flared stents and apparatus and methods for delivering them
WO2007136794A2 (en) * 2006-05-19 2007-11-29 Mpsc, Inc. Piercing tip
AU2007258592B2 (en) 2006-06-06 2012-10-25 Cook Incorporated Stent with a crush-resistant zone
US7905823B2 (en) 2006-08-30 2011-03-15 Circulite, Inc. Devices, methods and systems for establishing supplemental blood flow in the circulatory system
ES2528902T3 (en) * 2006-08-30 2015-02-13 Circulite, Inc. Devices and systems to establish complementary blood flow in the circulatory system
US8333686B2 (en) * 2006-08-30 2012-12-18 Circulite, Inc. Cannula insertion devices, systems, and methods including a compressible member
JP5411125B2 (en) 2007-03-29 2014-02-12 ノーブルズ メディカル テクノロジーズ、インコーポレイテッド Suture device and system for closing a patent foramen ovale
US9282967B2 (en) 2007-08-02 2016-03-15 Bioconnect Systems, Inc. Implantable flow connector
JP2010535073A (en) 2007-08-02 2010-11-18 バイオコネクト システムズ Embedded flow connector
US9168039B1 (en) 2007-09-06 2015-10-27 Cardica, Inc. Surgical stapler with staples of different sizes
US7988026B2 (en) 2007-09-06 2011-08-02 Cardica, Inc. Endocutter with staple feed
US8070036B1 (en) 2007-09-06 2011-12-06 Cardica, Inc True multi-fire surgical stapler configured to fire staples of different sizes
US8343029B2 (en) * 2007-10-24 2013-01-01 Circulite, Inc. Transseptal cannula, tip, delivery system, and method
US8262681B1 (en) 2007-11-23 2012-09-11 Rabin Gerrah Device and method for performing endoluminal proximal anastomosis
US8177836B2 (en) 2008-03-10 2012-05-15 Medtronic, Inc. Apparatus and methods for minimally invasive valve repair
US8771296B2 (en) 2008-05-09 2014-07-08 Nobles Medical Technologies Inc. Suturing devices and methods for suturing an anatomic valve
US8460168B2 (en) * 2009-03-27 2013-06-11 Circulite, Inc. Transseptal cannula device, coaxial balloon delivery device, and methods of using the same
US20100249491A1 (en) * 2009-03-27 2010-09-30 Circulite, Inc. Two-piece transseptal cannula, delivery system, and method of delivery
US8518060B2 (en) 2009-04-09 2013-08-27 Medtronic, Inc. Medical clip with radial tines, system and method of using same
US8668704B2 (en) 2009-04-24 2014-03-11 Medtronic, Inc. Medical clip with tines, system and method of using same
US8167898B1 (en) 2009-05-05 2012-05-01 Cardica, Inc. Flexible cutter for surgical stapler
US20110054487A1 (en) * 2009-09-02 2011-03-03 Circulite, Inc. Coaxial transseptal guide-wire and needle assembly
JP5638614B2 (en) 2009-09-14 2014-12-10 サーキュライト・インコーポレーテッド Intravascular anastomotic connector device, delivery system, and delivery and method of use
US8333727B2 (en) * 2009-10-08 2012-12-18 Circulite, Inc. Two piece endovascular anastomotic connector
WO2011079222A2 (en) * 2009-12-23 2011-06-30 Boston Scientific Scimed, Inc. Less traumatic method of delivery of mesh-based devices into human body
US9504776B2 (en) * 2010-02-11 2016-11-29 Circulite, Inc. Cannula lined with tissue in-growth material and method of using the same
US9750866B2 (en) 2010-02-11 2017-09-05 Circulite, Inc. Cannula lined with tissue in-growth material
US20110251450A1 (en) * 2010-04-12 2011-10-13 Pagani Francis D Method and Device for Attachment of an Inflow Conduit to the Heart and to a Pump
US10265200B2 (en) 2010-08-10 2019-04-23 Cook Medical Technologies Llc Medical prostheses having bundled and non-bundled regions
CN103228300A (en) 2010-09-07 2013-07-31 保罗·A·斯彭斯 Cannula systems and methods
EP2697721B1 (en) 2011-04-15 2019-09-18 Heartstitch, Inc. Suturing devices for suturing an anatomic valve
US8956377B2 (en) * 2011-06-15 2015-02-17 Empire Technology Development Llc Punch tool
US9283110B2 (en) 2011-09-20 2016-03-15 Zoll Circulation, Inc. Patient temperature control catheter with outer sleeve cooled by inner sleeve
US9259348B2 (en) 2011-09-28 2016-02-16 Zoll Circulation, Inc. Transatrial patient temperature control catheter
US9314370B2 (en) 2011-09-28 2016-04-19 Zoll Circulation, Inc. Self-centering patient temperature control catheter
US8888832B2 (en) 2011-09-28 2014-11-18 Zoll Circulation, Inc. System and method for doubled use of patient temperature control catheter
US10045881B2 (en) 2011-09-28 2018-08-14 Zoll Circulation, Inc. Patient temperature control catheter with helical heat exchange paths
US8585635B2 (en) 2012-02-15 2013-11-19 Sequana Medical Ag Systems and methods for treating chronic liver failure based on peritoneal dialysis
US9314600B2 (en) 2012-04-15 2016-04-19 Bioconnect Systems, Inc. Delivery system for implantable flow connector
US10434293B2 (en) 2012-04-15 2019-10-08 Tva Medical, Inc. Implantable flow connector
WO2013170081A1 (en) 2012-05-11 2013-11-14 Heartstitch, Inc. Suturing devices and methods for suturing an anatomic structure
US9801756B2 (en) 2012-09-28 2017-10-31 Zoll Circulation, Inc. Intravascular heat exchange catheter and system with RFID coupling
US9241827B2 (en) 2012-09-28 2016-01-26 Zoll Circulation, Inc. Intravascular heat exchange catheter with multiple spaced apart discrete coolant loops
US9433528B2 (en) 2012-09-28 2016-09-06 Zoll Circulation, Inc. Intravascular heat exchange catheter with rib cage-like coolant path
US9717625B2 (en) 2012-09-28 2017-08-01 Zoll Circulation, Inc. Intravascular heat exchange catheter with non-round coiled coolant path
WO2014062827A1 (en) 2012-10-16 2014-04-24 Spence Paul A Devices, systems, and methods for facilitating flow from the heart to a blood pump
USD743542S1 (en) * 2012-10-31 2015-11-17 Sequana Medical Ag Catheter with staggered slits
USD743543S1 (en) * 2012-10-31 2015-11-17 Sequana Medical Ag Catheter with staggered slits
US9144660B2 (en) 2012-10-31 2015-09-29 Sequana Medical Ag Implantable catheters with staggered slits, and methods of using same
EP3016598B1 (en) 2013-07-02 2018-10-10 Med-venture Investments, LLC Suturing devices for suturing an anatomic structure
WO2015085094A1 (en) 2013-12-04 2015-06-11 Heartware, Inc. Apparatus and methods for cutting an atrial wall
EP3079602B1 (en) 2013-12-06 2020-01-22 Med-venture Investments, LLC Suturing apparatuses
KR101514055B1 (en) * 2013-12-17 2015-04-21 주식회사 스텐다드싸이텍 Catheter for common hepatic duct
US9474644B2 (en) 2014-02-07 2016-10-25 Zoll Circulation, Inc. Heat exchange system for patient temperature control with multiple coolant chambers for multiple heat exchange modalities
US10500088B2 (en) 2014-02-14 2019-12-10 Zoll Circulation, Inc. Patient heat exchange system with two and only two fluid loops
US10792185B2 (en) 2014-02-14 2020-10-06 Zoll Circulation, Inc. Fluid cassette with polymeric membranes and integral inlet and outlet tubes for patient heat exchange system
US11033424B2 (en) 2014-02-14 2021-06-15 Zoll Circulation, Inc. Fluid cassette with tensioned polymeric membranes for patient heat exchange system
US9545263B2 (en) 2014-06-19 2017-01-17 Limflow Gmbh Devices and methods for treating lower extremity vasculature
US10178993B2 (en) 2014-07-11 2019-01-15 Cardio Medical Solutions, Inc. Device and method for assisting end-to-side anastomosis
USD809136S1 (en) * 2014-09-17 2018-01-30 Kirwan Surgical Products Llc Electrical connector and irrigation connector for irrigation cord assembly
US11359620B2 (en) 2015-04-01 2022-06-14 Zoll Circulation, Inc. Heat exchange system for patient temperature control with easy loading high performance peristaltic pump
US9784263B2 (en) 2014-11-06 2017-10-10 Zoll Circulation, Inc. Heat exchange system for patient temperature control with easy loading high performance peristaltic pump
US10537465B2 (en) 2015-03-31 2020-01-21 Zoll Circulation, Inc. Cold plate design in heat exchanger for intravascular temperature management catheter and/or heat exchange pad
US11213423B2 (en) 2015-03-31 2022-01-04 Zoll Circulation, Inc. Proximal mounting of temperature sensor in intravascular temperature management catheter
US10022265B2 (en) 2015-04-01 2018-07-17 Zoll Circulation, Inc. Working fluid cassette with hinged plenum or enclosure for interfacing heat exchanger with intravascular temperature management catheter
WO2017040264A1 (en) 2015-08-28 2017-03-09 Heartware, Inc. Dilation delivery system for a medical device
EP3442437B1 (en) 2016-04-11 2020-11-11 Nobles Medical Technologies II, Inc. Tissue suturing device with suture spool
EP3504656A1 (en) 2016-08-26 2019-07-03 Sequana Medical AG Systems and methods for managing and analyzing data generated by an implantable device
US11185440B2 (en) 2017-02-02 2021-11-30 Zoll Circulation, Inc. Devices, systems and methods for endovascular temperature control
US11116657B2 (en) 2017-02-02 2021-09-14 Zoll Circulation, Inc. Devices, systems and methods for endovascular temperature control
US11337851B2 (en) 2017-02-02 2022-05-24 Zoll Circulation, Inc. Devices, systems and methods for endovascular temperature control
EP4299086A2 (en) 2017-04-10 2024-01-03 LimFlow GmbH Devices for treating lower extremity vasculature
US11559618B2 (en) 2017-05-24 2023-01-24 Sequana Medical Nv Formulations and methods for direct sodium removal in patients having severe renal dysfunction
WO2018215917A1 (en) 2017-05-24 2018-11-29 Sequana Medical Ag Direct sodium removal method, solution and apparatus to reduce fluid overload in heart failure patients
EP3641663B1 (en) 2017-06-19 2022-03-02 Heartstitch, Inc. Suturing systems and methods for suturing body tissue
US11839370B2 (en) 2017-06-19 2023-12-12 Heartstitch, Inc. Suturing devices and methods for suturing an opening in the apex of the heart
EP3668415B1 (en) 2017-08-18 2023-10-25 Nobles Medical Technologies II, Inc. Apparatus for applying a knot to a suture
AU2019359268A1 (en) 2018-10-09 2021-04-08 Limflow Gmbh Devices and methods for catheter alignment
EP4051174A4 (en) 2019-11-01 2023-11-22 LimFlow GmbH Devices and methods for increasing blood perfusion to a distal extremity

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4577631A (en) * 1984-11-16 1986-03-25 Kreamer Jeffry W Aneurysm repair apparatus and method
US4769031A (en) * 1986-06-25 1988-09-06 Mcgough Edwin C Ventricular access device and method
US4861330A (en) * 1987-03-12 1989-08-29 Gene Voss Cardiac assist device and method
JPH088933B2 (en) * 1987-07-10 1996-01-31 日本ゼオン株式会社 Catheter
US5015238A (en) * 1989-06-21 1991-05-14 Becton, Dickinson And Company Expandable obturator and catheter assembly including same
US5089006A (en) * 1989-11-29 1992-02-18 Stiles Frank B Biological duct liner and installation catheter
US5395311A (en) * 1990-05-14 1995-03-07 Andrews; Winston A. Atherectomy catheter
US5217474A (en) * 1991-07-15 1993-06-08 Zacca Nadim M Expandable tip atherectomy method and apparatus
US5250060A (en) * 1992-06-26 1993-10-05 Carbo Paul L Angioplasty apparatus
US5431661A (en) * 1993-11-02 1995-07-11 Bipore, Inc. Adapter and mating trocar element for use in trocar assembly
US5556405A (en) * 1995-10-13 1996-09-17 Interventional Technologies Inc. Universal dilator with reciprocal incisor

Also Published As

Publication number Publication date
US5676670A (en) 1997-10-14
EP0910320A1 (en) 1999-04-28
WO1997047261A1 (en) 1997-12-18
JPH11512950A (en) 1999-11-09
AU3295197A (en) 1998-01-07
AU729340B2 (en) 2001-02-01
JP3322404B2 (en) 2002-09-09
EP0910320A4 (en) 2006-06-14

Similar Documents

Publication Publication Date Title
CA2257989A1 (en) Catheter apparatus and method for creating a vascular bypass in vivo
US6719781B1 (en) Catheter apparatus having an improved shape-memory alloy cuff and inflatable on-demand balloon for creating a bypass graft in-vivo
US5797920A (en) Catheter apparatus and method using a shape-memory alloy cuff for creating a bypass graft in-vivo
US6234995B1 (en) Apparatus and method for selectively isolating a proximal anastomosis site from blood in an aorta
EP1024753B1 (en) Perfusion-occlusion catheter
US5928181A (en) Cardiac bypass catheter system and method of use
US6443158B1 (en) Percutaneous coronary artery bypass through a venous vessel
US6090096A (en) Antegrade cardioplegia catheter and method
US20020049402A1 (en) Endolumenal aortic isolation assembly and method
US20220151634A1 (en) Vascular access devices, systems, and methods
AU766058B2 (en) Catheter apparatus having an improved shape-memory alloy cuff and inflatable on-demand balloon for creating a bypass graft in vivo
EP1281357A2 (en) Perfusion-occlusion catheter and methods
CA3005526A1 (en) Methods and devices for repair or replacement of heart valves or adjacent tissue without the need for full cardiopulmonary support
US20020033180A1 (en) Device, an introducer and a method for providing a supplemental flow of blood
EP0983027B1 (en) Device for partially occluding blood vessels
US20220193321A1 (en) Vascular conduit to facilitate temporary direct access of a vessel
WO2022133070A1 (en) Flexible shunt implants

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead